Index to volume 92

Number

1 January

Topical

Review

Diaphragm J.

D.

1998

shortening

Pierce,

R.

Hypo-osmolar

and intrathoracic L. Clancy,

aerosol

pressure

J. W. Trank

induces

hyperventilation

Serum N.

Oral

Laub,

study

Bisgaard,

H.

& H.

rhinitics

& A.

Ciaccia

in tuberculous

S. Chan,

and its metabolite

P. Munch

Nikander

corticosteroid

J.

6.

pleurisy K.

Leung,

F. Reichenberger,

monoethylglycinexylidide

during

fibre-optic

&

bronchoscopy

in local

anaesthesia 40

R. Angelo

as a nebulized

suspension

vs pressurized

metered-dose

inhaler

in adult

asthmatics 44

& E. Munch

treatment

during

and mortality

long-term

oxygen

therapy

in chronic

obstructive

pulmonary

disease:

a risk factor

for

in women 50

factors

that

Fujimori

& M.

affect

blood

gases in non-smoking

women

with

chronic

liver

Blood E. Juel

eosinophil

and monocyte

Jensen,

B.

counts

Pedersen,

are related

and complaints

M. J. Kampelmacher, J-W. J. Lammers

of patients

R.

G. van

J. Staal-van

57 3%!

inflammatory

& R.

11”19-F-s “57

and lung function 63 ?~W7T~~jl3 z * “..

Dahl

IW + T”m*:I- ?a”,?T m I-YT’W’rn~S + mimsPpu+ ‘rn~~~iv T-r?? prescribed

Kesteren,

long-term G.

oxygen

P. J. Alsbach,

therapy C.

in the Netherlands F. Melissant,

H.

J. Wynne,

J. M.

C.

Douze

&

70 ~~~~~~~,~,,~~~~~

The enhanced

to smoking

E. Narvestadt

I Texas,ww,nm ?TS1Y~~~?;“I~~,~:‘~~~~,~‘~4EP’~I~”~‘CXlt Characteristics

disease

Arakawa

*;.a,Tma T~~D-~~~,,1%‘~~1~~!~~’ x ‘Lra* -x”1p”,7iE”~~T‘+~I W’T’rx m”w,~‘~P,ww: F’.‘! iza?mr“---“xE-~~~3,~~

A.

J. Schauer

Strom

Clinical K.

E.

C.

in rats

non-asthmatic

Micheletto

cytokines

Roth,

of budesonide

K.

hospitalization K.

M.

of lignocaine

M.

Comparative H.

Izbicki,

concentrations

Milman,

C.

of pro-inflammatory

G. Hoheisel, G. A. P. Perruchoud

hypercapnia

Burris

in chronic

gagnoli,

Compartmentalization

during & J.

response

m -v-~~~r I, _m

in non-small

cell lung carcinoma

is not reflected

den Brekel, M. A. Dentener, M. Drent, G. P. M. ~WC’iwinar’m?--n~m.w”swar, - 1“mlw~~‘w~ ~~~‘+ag~~-~~filsrr‘Jix~~I~~~,~~~

ten

in the alveolar

compartment

Velde, W. A: Buurman ~al~~~~~~l~i:?‘*‘~~l~rrgp~,‘~

& E. F. M. i?rf*m

Wouters

76 “n-m- 1

Do patients using long-term liquid oxygen differ from those on traditional gas cylinders? A comparison of two national registers J.

Schaanning,

K.

Stream

& J.

treatment with oxygen concentrators and/or compressed 84

Boe

Differences in sensitivity, maximal response and position of the concentration-response patients with allergic rhinitis and healthy subjects

curve to methacholine between asthmatics,

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less N.

C.

Barnes,

C.

Hallett

& T. A.

J.

95

Harris

nwi

A comparison of the performance of two modern multidose dry powder asthma inhalers L. S.

Hill

& A.

L. Slater

Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic@ as efficacious as nebulized budesonide in adult asthmatics? J.

F. O’Reilly,

Case

D. C.

Weir,

S.

Banham,

G.

S. Basran,

G.

Boycl

& K.

R.

Pate1

111

Reports

A case of allergic bronchopulmonary Y. Nikaido,

N.

Nagata,

aspergillosis successfully treated with itraconazole

T. Yamamoto,

C.

Yoshii,

H.

Ohmor~i’&

M.

Kido

118 %

Pulmonary cryptococcoma with CD4 lymphocytopenia C.

L.

Ho,

B.

C.

Chang,

G.

C.

Hsu

& C.

and meningitis in an HIV-negative patient

P. Wu

nmz Reactive amyloidosis in a patient with Mycobacterium simiae pulmonary infection A.

Aharon,

Number

P. Langevitz,

2 February

R.

1998

Editorial Topical

Reviews

Sarcoidosis: historical perspective and immunopathogenesis G. Zissel

& J.

(part I) 126

Miiller-Quernheim

Sarcoidosis: clinical manifestations, staging and therapy (part II)

Health habits and illness behaviour: social factors in patient self-management

Original

Articles

Ventilation in a Birmingham intensive care unit 1993,-1995: outcome for patients with chronic obstructive pulmonary disease r A.

T. Hill,

R.

B.

Hopkinson

& D.

E. Stableforth

156 %I

Budesonide but not terbutaline decreases phagocytosis in alveolar macrophages A.

Zetterlund,

P. H.

Ldrsson,

C.

Mi.iller-Suur,

L.

Palmberg

& K.

Larsson

162

Measurement

of hepatocyte

H. Yamanouchi,

The effect

& P. J.

factor

in serum

and bronchoalveolar

T. Yoshinouchi,

of oral corticosteroids

2. Corden

Are

growth

J. Fujita,

S.

on bronchodilator

Hojo,

lavage

T. Kamei,

responses

fluid

in patients

I. Yamadori,

with

pulmonary

Y. Ohtsuki,

N.

fibrosis

Ueda

273

& J. Takahara

in COPD

Rees

symptoms

of obstructive

the Obstructive

Lung

279 sleep apnoea

Disease

syndrome

in Northern

related

Sweden

to bronchitic

symptoms

or lung function

impairment?

Report

from

Study 283

Improving

communication

between

hospital

and primary

care increases

follow-up

rates for asthmatic

patients

following

casualty

attendance P. H. Johnson,

1. Wilkinson,

A comparison

of regular

A.

salmeterol Blic,

One-year

economic

Sut

A

vs ‘as required’

M.

evaluation

M.

la Rosa

salbutamol

P.-H.

of intensive

Kaad

therapy

& A.

vs conventional

289 in asthmatic

children

Moorat

patient

education

and su

patients R.

00

Cold

air inhalation

patterns K-H.

and exercise-induced

in asthmatic

Carlsen,

Asthma,

children

G.

type-l

Engh,

allergy

bronchoconstriction

and children

M.

Merk

and related

with

in relationship

other

chronic

lung

to metacholine

bronchial

responsiveness:

different

diseases

& E. Schrmder

conditions

308

in 7- and g-year-old

nsson

children

inNorthern

Sweden:

prevalence

rates and risk

factor

pattern 316 WmzP

ts-Mil

l,~%4BKCU Safety

and efficacy

patients E.

with

of a high cumulative

dose of salbutamol

inhaled

via TurbuhalerO

or via a pressurized

metered-dose

inhaler

in

asthma

Bondesson,

K.

Friberg,

S. Soliman

& C.-G.

325

Lofdahl

~~~~~~~‘~~~,,~~~~~ Haemodynamic

response

during

initiation

of non-invasive

positive

pressure

ventilation

in COPD

patients

with

acute

ventilatory

failure M.

Confalonieri,

P. Gazzaniga,

L. Gandola,

S. Aiolfi,

R. Della

Porta,

A.

Frisinghelli

& A.

Bellone

331

~~~~~‘~~~~~~~~~~~~ Interleukin-8

expression

A.

C.

Xaubet,

in bronchoalveolar

Agusti,

lavage

P. Luburich,

J. A.

cells in the evaluation Barber&

M.

Carrion,

of alveolitis M.

in idiopathic

C. Ayuso,

J.

pulmonary

Rota

& R.

fibrosis 338

Rodriguez-Roisin

lmmxw‘

Short Time

Reports

trends

and seasonal

F. T. Chew,

Fluticasone

variation

D. Y. T. Goh,

propionate:

in acute

B.

C.

an audit

Ooi

childhood & B.

of outcomes

W.

asthma

in tropical

Singapore

Lee

and cost-effectiveness

in primary

care

J.

A comparison

of bronchodilating tera,

ZZO

effects F. Di

of salmeterol Perna,

ro,

!Bmxa

Case Apical

bromide

in stable

chronic

obstructive

pulmonary

disease

o & A. Vinciguerra ,~~~~~~~~~~~~~~~*~

Reports pleural

T.‘Williams,

Rhabdomyolysis R.

and oxitropium

P. Byrd

mass developing

following

B.

D.

Gostelow,

and bacterial Jr

& T. M.

Roy

Woods

talc pleurodesis & T. Spyt

358

pneumonia 359

Number

3 March

Topical

1998

Reviews

Prediction

equations

for forced

spirometry

J. ems

The T cell receptor S-T.

Uh,

S. L.

subsets

S. Y. Ki,

of lymphocytes

G-l.

Chisholm,

Lim,

F. W.

Nocturnal

oxygen

S. Andreas,

‘n,-

S.

in bronchoalveolar Moon,

A.

and hypercapnic

S.

W.

Knuistingh

ventilatory

r Miihlen,

at fibre-optic

Kristensen,

Long-term

N.

populations

Stevens

& I-L.

Jarnvig

lavage

Jeong,

H.

Neven

& H.

response

J.

mechanical

bronchoscopy Milman

ventilation

R.

in patients T. Kim,

with

Y. H.

active

Kim

pulmonary

& C.

tuberculosis

S. Park

421

Petri

“7 “~-“1”3”~

* a-mrrsm’v~‘men’.raa%mm% 7m!!wvs

in patients

with

% H.

Effect

of oral

Hasani,

E. Farrero,

congestive

heart

failure 426

Kreuzer

antibiotics

on lung

S. Rotondetto,

~nb-lll~~~‘Ol~~~~,~~~~~~~‘“~ Peripheral H.

Carr,

airways S.

mucociliary

oxygen

M.

on high-resolution Rubens

& K.

supplementation?

sclerosis

Monasterio

clearance S.

for postbronchoscopy

432

lateral C.

indication

& F. Manresa

W.

during

Clarke,

-*“‘T*-:~mii‘-~~~~~~m~~ exacerbation

M.

A.

of chronic

Spiteri

& J.

obstructive

E. Agnew

?“p 14.1“XI:%“nn y”y ~~~~~~~~~~~~~~~~ i’ wmF6rn’mP‘I[TF lwlg’,‘+“‘ilp7 =

obstruction Hibon,

anaesthesia:

8:x”?&-“Bivi-l%l ?-a 7s As-2 Pmw-r““19rPl-T-P

D.

Pavia,

in local

in amyotrophic

Estops,

i?9-wl!m~w’s’n_w ‘~,~~~~~~~~~~~,~~,

m-

origin

* w”q~r3~-‘&l’w--m+ni-mT

J. Escarrabill,

D.

European

~~s’~~.~m~r’~~~‘~~~~~‘inw,~‘ar.~-g-p

F. van

Pulse oximetry

A.

S. H.

Dekker,

w~~~~i69u’i”~~iaR6~~,~~~~~

1

M.

from

s, J. Sunyer, J. A. Barbers & J. Rota “9ww*R~~~7L(BUn~T’~mmw1z ‘“J‘“~,,,. ““~“I”I’f”‘l?i~~~~,~~~~~~g’c619%”~~~l,?n~r~~’,;~~‘~!~~rrIn~~~~~ ”

computed F. Chung

tomography

in chronic

severe

asthma

pulmonary

disease

Prediction J. J.

equations

for plethysmographic

lung

volumes

Rota, F. Burgos, J. A. Barber&, J. Sunyer, M. Antbo, P. Casan & J. L. Clausen

Non-adrenergic, T. W.

non-cholinergic

Mackay,

G.

The European

function

Hulks

& N. J.

Respiratory

R.

Rodriguez-Roisin,

J.

Castellsague,

J.

Sanchis,

454

in the human

airway 461

Douglas

Society

study

on chronic

stma,

L. A.

obstructive

pulmonary

disease

(EUROSCOP):

recruitment

methods

and

strategies Laitinen,

S. V. Ohl

467

R. A.

imDFm Phase

II trial

of intrapleural

ng,

Prevalence

Y.-M.

of bronchial n,

Diagnostic A.

e,

of closed

& G.

Radiographic J. T. R.

a high

pleural

L.

patients

with

malignant

central

and northern

parts

pleural

effusions

of Sweden

Rosenhal

biopsy

incidence

son

vs pleuroscopy

of tuberculosis:

in suspected

a comparative,

malignant

pleural

age-dependent

effusion

or tuberculous

study 466

of adult

pulmonary

D. S. Askgaard,

A comparison

of different

H.

K.

Koyama,

cancer

Rezaian

spectrum Wilcke,

n,

E

lung

Chou,

in the southern,

percutaneous

with

R.

for non-small-cell

K.-C.

hyper-responsiveness

in a region

Emad

injection

M.-F

P.

value

pleurisy

paclitaxel

Chen,

methods

Nishimura,

tuberculosis

B.

Nybo

of spirometric A.

Ikeda,

in a developed

Jensen

& M.

measurement

M. Tsukino

country 493

Dessing

selection 498

& T. lzumi

rnrn$

Comparison H.

of four

types

K.

Nishimura,

Koyama,

of portable A.

peak Ikeda,

flow

meters

M.

Tsukino

(Mini-Wright, ,m

Assess,

Pulmo-graph

and Wright

Pocket

meters) 505

& T. lzumi

&wBd& N-Acetylcysteine K.

inhibits

Matsumoto,

Lung N.

IL-la-induced

S. Hashimoto,

function

in patients

Tzanakis,

D.

-m*am

-Lam a

Long-term

nasal

with

Bouros,

inflammatory M.

intermittent

IL-8

secretion

Y. Gon,

bowel

Samiou,

positive

by bronchial

T. Nakayama,

cells 512

& T. Horie

disease

P. Panagou,

pressure

epithelial H. Takizawa

J.

ventilation

Mouzas,

in patients

0.

with

Manousos

cystic

& N.

fibrosis

516

Siafakas

and hypercapnic

respiratory

failure

(1991-1996) A.

T. Hill,

Predicting

F. P. Eden

cognitive

decline

in pa , M.

Oxygen,

arterial

C.-C.

blood

gases and ventilation

P. Torrice

are unchanged

during

n, Y.-H.

Huan

Tsai

A.

Gemma

dialysis

& R.

in patients

Pistelli

receiving

7 % pressure

support

ventilation

& T. C. Y. Tsao

534

Bcz Prednisolone

in acute

S. .Langton

Hewer,

Effect N.

of nasal

Mygind,

Leukocyte

J.

counts

Dahl

asthma:

Hobbs,

inflammation R.

A. Di France, P. Macchioni,

childhood

clinical

F. Reid

and of intranasal & L.

in hypertonic B. Vagaggini, L. Ruocco

responses

& W.

to three

dosages 541

Lenne

anti-inflammatory

treatment

on bronchial

asthma 547

P. Nielsen

saline-induced

sputum

E. Bacci, M. & P. L. Paggiaro

in subjects

L. Bartoli,

S.

with

occupational

Cianchetti,

asthma S. Carnevali,

F. L.

Dente,

D.

Giannini,

550 ‘~~~‘R~~~~~~~~~~~~~~-~.i?~~~(~

Number

4 April

1998

The use of home

nebulizers

P. Demoly,

D.

Jaffuel,

Original

Articles

The measurement R.

Carter,

in adult

asthma

H. Sahla,

J.

of the single-breath

0.

A.

Al-Rawas,

Bousquet,

transfer

R.

F.-B.

factor

Michel

for carbon

D. Stevenson,

S.

624

& P. Godard

monoxide

K. Naik

and its components

& D.

using

the Morgan

Transflow

system 628 Bs!se

J. Wheatley

‘SrniE Curved H.

chest tube

Ishikawa,

Prescribing A.

for drainage

H. Satoh,

for persistent

Picciotto,

M.

of malignant

pleural

Y. T. Yamashita,

H.

cough

effusion Kamma,

T. Naito,

M.

Ohtsuka

& S.

633 m

Hasegawa

in children

Hubbard,

P. Sturdy,

J.

Naish

& S. A.

McKenzie

638 mm

Variations

in hospitalization

rates

for asthma

among

Black

and minority

ethnic

communities

iffith

HLA-DQBl M.

and HLA-DPBl

Schiirmann,

Improved M.

Norman,

of life following

brushing:

protein

J. Miiller-Quernheim

increased

elastic

L. Jorfeldt,

F. Larsen,

a new method

for diagnosis

recoil

6

& E. Sch

after

lung volume

K. Cederlund,

reduction

G. Zetterberg

of malignant

pleural

surgery & G.

Palen,

S. 0.

653

Unge

effusions

1

measurements

in exacerbations

guidelines J. J.

Klein,

J. Cunniffe,

in self-management G. A.

of chronic J. R.

W.

education

Zielhuis

& C.

obstructive

Govan,

for adult

L. A.

Van

pulmonary

C.

G. Wathen

disease & F. X. S.

Emmanuel

between

subjective

Breukink,

J.

H.

fatigue

Strijbos,

asthmatics 668 %9mmsx

and physiological M.

Koorn,

G.

664 .%z??

Herwaarden

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Relationship

in emphysema

659

R. Sankaran,

role of self-treatment der

sarcoidosis

Schlaak,

Rezaian

E. Wallace,

J. van

M.

L. Orre,

pleural R.

of C-reactive

Dev,

The

Hillerdal,

& G.

in familial

Kirsten,

and quality

percutaneous

Emad

Value D.

G.

genotypes

Bei

lung function

Closed A.

G.

42 sm

variables H.

in patients

Koeter,

E. H.

with

Breslin

chronic & C.

obstructive P. van

der

pulmonary

disease 676

Schans

.‘ Long-term

treatment

S. Nutini,

of asthmatic

T. Martini

& R.

patients

with

salmeterol

YS slow-release

theophylline 663

Righi

~~~~~~~~~~,~~~~~~~~I

Short Finger C.

Report clubbing

McGavin

Case

in malignant

mesothelioma

and benign

asbestos

pleural

:i

disease

691 aam

& P. Hughes

Reports

Pneumonia

caused

J.

K.

Fujita,

by Pseudomonas

Negayama,

M.

putida Ohara,

with S.

a mucoid Hojo,

phenotype

Y. Obayashi,

H.

Miyawaki,

Y. Yamaji

& J. Takahara

693

lemmLs:la

Lobectomy R.

in cystic

Bragonier,

Cardiac M.

%,

D.

sarcoidosis:

J. Doherty,

S.

fibrosis Grier,

F. Carswell

the value

of magnetic

Kishore

Kumar,

L

& S. Cunningham

resonance A.

A.

imaging

Nicholson

in diagnosis & D.

and assessment

V. McGivern

of response

695

to treatment 697

866~

hew

s .wwd

Bilateral M.

endobronchial

J. Doherty,

Response

T. Tsang,

abscess

K. E.

Letters

to the

of adult

cell lung

cancer

to chemotherapy 788

lining & I. Reintoft

bronchial

Selcuk

asthma

in Turkey

and @phi

1998

Topical

Review

Leukotriene

antagonism

in asthma

and rhinitis

Lane

Original Total

non-small

786

Greenstone

k & L. Coplii

to Drs Kalyoncu,

S. J.

with

osteosarcoma & M. A.

Ip

epithelial

2. T.

6 June

E. Cowan

Editor

studies

. F. Kalyoncu,

Number

& M.

J. I. Jensen

Epidemiologic

Reply

Lam

squamous

Bendstrup,

M.

co-existing

W-K.

with

due to a chondroblastic

P. Campbell,

of dermatomyositis

K. W.

Lung

metastases

A.

Articles

respiratory

system

K. Shiraishi,

H.

compliance

Sasaki,

M.

after

thoracoplasty

Yaekashiwa,

M.

Motomiya

810

& T. Nukiwa

T-m? Rapid

diagnosis

bronchial

of smear-negative

aspirates

pulmonary

as an adjunct . Yew,

C.

tuberculosis

to transbronchial

Y. Chan,

L. Y. Au,

E~~~llm,CT”~~“‘~~~~~~~~~~~~.‘~~,~~ Prescription centre

of nCPAP

and nBIPAP

via fibreoptic

bronchoscopy:

utility

of polymerase

chain

reaction

in

biopsies S. W.

Cheung

& A.

F. 6.

815

Cheng

‘~‘~~~~~~~~~~~~‘,~~~ o~~i~g;n$s~~iccxB’~~,~~~~~,~~-~~~,~~~~

in obstructive

sleep apnoea

syndrome:

Italian

experience

in 105 subjects.

A prospective

two

study Picca,

Tension-time yot,

index

R.

of inspiratory

Sabato,

muscles

P. F. Perrigault,

M.

in COPD

Rizzi,

F. Scarpelli

patients:

V. Gautier-Dechaud,

X.

& M.

role of airway Capdevila,

Sergi

obstruction J. Milic-Emili,

Ch.

Prefaut

& M.

airways

disease

Ramonatxo

828

;~~~~Bilki~~~~“~,i911”~“~~~~~j~~~~~~~~~~,~,~~~~~~~~,~,~~~~~~~,~,~~~~~~~~~~,~~,~,~~~~~~~~~~~~~~~~~~~~~,~~~~~~~~~ A 6-month

comparison

between

D. Vervloet, T. Ekstrom, & G. Di Benedetto

Comparison

of the severity

K. C.

& A.

Ong

Symptoms S. M.

A.

formoterol R.

Pela,

and salmeterol F. Duce

Gracia,

in patients C.

Kopp,

with 8.

reversible D.

obstructive

Silvert,

E. Quebe-Fehling,

G.

Della

836 of sleep-disordered

breathing

in Asian

and Caucasian

patients

seen at a sleep disorders

center 843

Clerk

and pulmonary

Cioppa

function

in asthma

Alcock, M. Mamun, R. J. Prescott & C. K. Connolly 1 _I - Lmasji;ip’~l~~~~~~~~~~.l$i:F~~~“‘~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~,~~~~~~~~~~~~.~~~~“~~~~~~~.~~~~~~~~~~~ ~~~~~~~~~~~~,~~~ ma&%&E~mLBrarL

849

Case

Reports

Multiple

drug-resistant

H.

Shishido,

Nocardia

K.

.$ ‘q,-(f??#l”n “#‘“” yyI “‘““*“y i Chest

X.

Solitary M.

utility

Thymic

in lung

Muiioz,

columnar

Henry,

S.

A.

bronchial

R.

from

a patient

S. Akagawa

with

& G.

papilloma:

a rare endoscopic

finding

F. Kealy & C. P. Bre 1-mw= lWT*“WWW, ‘!F=-$?I, _

with

mutinous

stroma:

a case report

mediastinal

nonseminomatous

germ

cell tumour

in an adult

M. Satoh

L. A.

bronchiolitis

obliterans

de

J.

Perez

Llano

with

organizing

L. Soilan,

M.

pneumonia

J. Garcia

female

presenting

Pais,

& S. Abe i

Y. Morishima, H. Satoh, M. Ohtsuka, T. Yazawa, Y. Yamashita mrw9w -RYEma.~Tx~8~ ~mv~‘!aKTs-rn,h., --w-La,--“-c‘3~,~~‘?E’1~~~~,~.~~~~~~~~~~ a.

Idiopathic

873

Sampol

T. Ohchi, H. Tanaka, Y. Shibuya, T. Shibusa, M. Inuzuka, ,:~~.~ri31”P’rB!T+~~~~~~~‘~~~~~r?-9~”f’~iiPCn~~~~“~~~~~~~~~,~~~~~~.~~~~~~~~~.~~~~~~~~~, i,n. i

Primary

pulmonarynocardiosis

& Y. Yoshizawa

endometriosis

Alvarez

L

carcinoid

isolated

Miyake,

2’ -3:xX”%:m. L ,‘8?.k ,‘a: : **” 4 ^*lmfA.‘x”Sr*~~~%:P’~IPfi’~:il;ga,itw,mps. ?w- :-Ei”~74?~rxz

CT scanning:

R. Orriols,

ustevoides

Deguchi,

I. Mata,

& S. Hase ,#lewAFmmm

with

adult

M.

respiratory

Moreda

& B.

distress

syndrome 884

Laserna

TIs~~?E’~“~EG:*$“~~~~‘~~~~.~~ t 11BL-‘-~-%!xwE~ G-8 I wlT”‘ci32m? T 3%w2~‘rL”?a~%~,iM+sn5”“l”lp-i Diffuse

pulmonary

Y. ikeda,

Pleomorphic J.

3,“:

B. J.

and severe tracheal

M.

Pannekoek

of central

Boudewyns,

spontaneous

apnoea

P. Van

7 July

Topical

in a patient

with

bronchial

asthma

& S.

in a patient de

obstruction H.

treated

Heyning

889

Overdiep

& W.

by auto-CPAP De

and obstructive

sleep apnoea 891

Backer

‘c-% nrc:si”vw, zEm-xTa-3mmm?.T’

1998

Reviews

Interrelationship for treating

between acute

M. Cazzola & M. ‘i ;Il”%s ~W ,-1”1’1i ,T”.X

Original Exhaled

pneumothorax

887

/ ., r~~‘l~nR,~~~~~~~~~~‘~I-l^iCln‘~~l~~’~~~(iil~~‘ll^~~~8

Number

M.

n and recurrent & T. Tamura

adenoma

Pomp.

Appearance A.

ossi

H. Yamashita

pharmacokinetics

exacerbations G.

of chronic

and pharmacodynamics

in choosing

the appropriate

antibiotic

and the dosage

regimen

bronchitis 895

Matera

Articles nitric

K. AI-Ali,

oxide; C.

relationship Eames

to clinicophysiological

& P. H.

Howarth

markers

of asthma

severity 908

Spirometric reference equations for older adults W.

F. McDonnell,

P. L. Enright,

D.

E. Abbey,

Cigarette smoking decreases interleukin-8 T. Ohta,

N. Yamashita,

M.

S.

F. Knutsen,

J. A.

Peters,

R.

J. Burchette

8. M.

D.

Lebowitz

secretion by human alveolar macrophages

Maruyatih,

E. Sugiyama

& M.

Kobayashi

The role of domestic factors and day-care attendance on lung function of primary school children K. /

Demissie,

P. Ernst,

L. Joseph

& M.

R.

,.

Becklake

928

‘~B#ba

Time course of respiratory decompensation in chronic obstructive pulmonary disease: a prospective, double-blind, study of peak flow changes prior to emergency department visits G.

H.

Murata

C.

0.

Ka wm”PiQ

methasone dipropionate

on bronchial mucosa and

asthma symptoms in patients with atopic asthma M.

Hoshino,

Y. Nakamura,

J. J. Sim

& H.

942

Tomioka

Effect of hyperoxia on human macrophage cytokine response V. Cazals

Short

Technical

& A.

951

Clement

Note

Drainage of spontaneous pneumothorax

using an intravenous catheter. Immediate and long-term results

E. Maury,

Moty

Case

F. Doyon,

Guidet,

A.

& G.

961

Offenstadt

Reports

Broncholithiasis: A.

B.

S. Nollet,

rare but still present J.

F. Vansteenkiste

A case of lymphomatoid

& M.

G.

963

Demedts

granulomatosis mimicking sarcoidosis ice

Salmonella empyema following splenic biopsy

Pulmonary infarction revealing pulmonary Takayasu’s arteritis M. G Iiii

‘aa#aa

Invasive pulmonary aspergillosis in an insulin-dependent S.

M.

Janes

Y. Suzuki

K.

F. Barker

S. Suzuki

M.

diabetic

V. Mak

Numata

Y. Matsumoto

J.

Suzuki,

H.

lkeda

& T. Okubo

Diagnosis of pulmonary veno-occlusive disease: new criteria for biopsy L. Valdes, wr

J. R.

Gonzalez-Juanatey,

D. Alvarez,

J. Antunez,

J.

Manuel

Valle,

P. Penela

& R. Alvarez-Sala

979

Transient cortical blindness: a complication of bronchial artery embolization S.-F.

Liu,

T-Y.

Lee,

S.-L.

Wong,

Y.-F.

Lai

&A.-S.

983

Lin

Pulmonary vasculitis associated with anti-Jo-l antibodies I. Brown,

C.

Joyce,

P. G.

Hogan,

J. Armstrong,

R.

Steele

& A.

S. Bansal

986

Number

8 August

Original

1998

Articles

An increase

of soluble

Fas, an inhibitor

of apoptosis,

associated

with

progression

of COPD

N. Yasuda, K. Gotoh, S. Minatoguchi, K. Asano, K. Nishigaki, M. Nomura, H. Kumada, T. Sawa & H. Fujiwara i ,I’*“.s.X’lBI” g,q,er;“:inq.~,~““X”-g,pp,a rq /’ E+T-hETIf -qlwrr I,,Bvy.“TW’SIIWP+“Z:‘r ,pw VWx mm U’CSCrl @MS I i I’ i ,“’ A!81 i: f.&

Starting A. J.

home

nebulizer

Simpson,

P. M.

Hospitalization C.

therapy: Tweeddale

for lung

Svanes,

patients’

disease

A double-blind

G.

P Wl”P”~~

& G.

in early

E. Omenaas,

i ill”-: xgv-e-m!.?v-~~~“~”

expectations

E.

reversibility

study

to salbutamol

M. Watanabe,

H. Sane,

993 ‘m’“1mb+

‘V -* ?#:1*-’ $‘?. g s,*,‘ -a&, =**a-*‘.&$

childhood

* 52; i”

at 2 months 1000

K. Crompton

and asthma

symptoms

in young

adulthood

0. Fluge & A. Gulsvik 1003 r ~Fisiur~vP“l”l(‘I i ‘” I VW.2‘CXC1 ll’li“VT‘pm B’“3r-f -p”vaFs!! #-?m,@lrwrq~%mwnjw .vpn,a,met” J~Ppppv~ ##p-i 2g‘““t-‘,*im,m.tyqv=m,1:*clTamp*$,-q

of the effect

of influenza

D. W. Reid, C. L. Bromly, S. C. Stenton, D. J. Hendrick 1a’-% XI”.~.‘UarXu?;7~iSE~~~~~~~~~~IC~~‘L!i99,ffl””i~, f rml’%:-UTg 6W s i P.,‘;b.ilp’, “,k9Bi$?’

Early

outcome

Ohno,

Eide,

tw=%-w~r

placebo-controlled

and subsequent

A.

does not always

predict

vaccination

on airway

responsiveness

in asthma

& S. J. Bourke p#~&‘x~g ,E! “iQ”mlf n~t~‘YwTS‘?-”“ID- z?!!mK3‘I% “mm %mPa’xm?3L” rw’~,~~~~~~~~~~~,,

bronchodilation

after

salmeterol

in stable

chronic

obstructive

1010 ~Bn~~imiTJlli

puhnonary

disease

(IL-lra)

in peripheral

Z. Wang,

Does M.

A.

Mann

the number Carrera,

blood en,

P. Malmberg

of hypopnoeas

F. Barb6

& A.

& K.

influence G.

therapy

Larsson

in patients

with

obstructive

sleep apnoea? 1028

N. Agusti

“a~,--,~‘“iI-Iwil~,~~~,~~‘~~~‘~ j~~,b?RxJ’BQn^isam-Q& e.~“X’*~~,~ran’-iril* := n_ *, (_, Early

transition

to oral antibiotic

therapy

for community-acquired

pneumonia:

duration

of therapy;

clinical

outcomes,

and cost

analysis 1032

1040

1046

The cardiorespiratory salbutamol S. M.

S.

response

and high-dose

Revill

&

D. Aaron

M.

R.

D.

to submaximal inhaled

L.

exercise

in subjects

with

asthma

following

pretreatment

E. Dales

in anaesthesia

bypass

controlled

release

oral 1053 Jim

Morgan

& B.

1059

Pham

JwE*~ra Change

with

salmeterol

practice

and postoperative

sedation

shortens

ICU

mkn

and hospital

length

of stay following

coronary

artery

surgery An

Ds

1

an0

%immi. Is gastro-oesophageal

reflux

a factor

in exercise-induced rnberg

G.

Liistro,

P. Rombaux,

Case

mycetoma

T. Abel,

S.

Migratory M.

Dury,

2.

T. Pieters,

Fireman

G. Aubert

& D.

probably

Parwer

& S.

pulmonary

C.

due to Cundida C.

1076

Rodenstein

albicans

with

complete

resolution

Sanyal

infiltrates

Rodriguez,

M.

Capurro,

F. Gomez

& M.

D.

1081

Ludefia

I

mml?xI

A case of diffuse M.

0.

Reports

Pulmonary A.

M.

asthma?

D. Zarnir

Abe,

S.

panbronchiolitis

Hashimoto

effectively

& H.

treated

with

low-dose

macrolide

antibiotics

and leukotriene

D,/E,

receptor

antagonist 1084

Hara

I'm Unique

pulmonary

presentation

of intravascular

large

cell lymphoma 1087

s, ns'%xT Pulmonary

veno-occlusive x,

disease

complicating

Felty’s

syndrome 1089

M.

Number9September1998

Original Increase

Articles in non-specific

a pilot M.

C.

T. E.

bronchial

hyperresponsiveness

without

specific

Rohde

& G.

response

to isocyanate

in isocyanate-induced

asthma:

study Kopferschmitt-Kubler,

N.

Frossard,

G.

1093

Pauli

Hallas

Glucocorticoid S. H.

1099 receptor

Korn,

F. B.

mRNA

J. M.

levels

in bronchial

Thunnissen,

G.

epithelial

cells of patients

J. Wesseling,

J.-W.

with

Arends

COPD: & E.

Influence F. M.

of glucocorticoids 1102

Wouters

m?w The A.

Scottish N.

Comparison chronic D.

multi-centre

McLean,

Patakas,

P. d’A.

prospective Semple,

study D.

H.

of bronchoscopy Franklin,

of the effects of salmeterol and ipratropium obstructive pulmonary disease D. Andreadis,

E. Mavrofridis

I for bronchial

G. Petrie,

E. A.

bromide

on exercise

& P. Argyropoulou

carcinoma Millar

and suggested & J. G.

performance

audit

standards 1110

Douglas

and breathlessness

in patients

with

stable 1116

Short

Communication

Case

Reports

Number

10 October

1998

Single centre open study to compare patient recording of PRN salbutamol use on a daily diary card with actual use as recorded by the MD1 compliance monitor S.

Hamid,

J.

Kumaradevan

& G.

M.

1188

Cochrane

Exercise training improves recovery in patients with COPD after an acute exacerbation

The use of a neural network for studying the relationship between air pollution A.

Nutman,

Y. Solomon,

S. Mendel,

J.

Nutman,

E.

Hines,

and asthma-related emergency room visits

M. Topilsky

& S.

Kivity

1199 )Iaa

Improvement in patient compliance with long-term oxygen therapy following formal assessment with training D.

G.

Peckham,

K.

McGibbon,

J. Tonkinson,

G.

Plimbley

& C.

1203

Pantin

Asthma health status measurement in clinical practice: validity of a new short and simple instrument E. A.

Barley,

F. H. Quirk

& P. W.

1207

Jones

Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation E. Clini,

C.

Sturani,

R.

Porta,

C. Scarduelli,

V. Galavotti,

Mild experimental exacerbation of asthma induced by individualised evaluation K.

M.

Vitacca

& N. Ambrosino

1215

low-dose repeated allergen exposure. A double-blind n,

Quality of life in elderly patients with COPD: measurement and predictive factors A r.s!ji’

Consistent effects of high socioeconomic status and low birth order, and the modifying effect of maternal smoking on the risk of allergic disease during childhood S. A.

Lewis

& J.

R.

1237

Britton

Pulmonary function threshold for distinguishing ventilatory- and nonventilatroy-limited G.

Fink,

J.

Case

Lebzelter,

D. Turner,

E.

Klainman,

M.

Shlomo,

I. Katz,

M.

patients with airflow obstruction

Kramer

& S. Spitzer

1245

Reports

Gastroesophageal reflux presented with haemoptysis and carinal erythematous lesion resembling in situ carcinoma D.

Bouros,

N.

Tzanakis,

K.

Psathakis,

G.

Patsourakis

& T. Rokkas

1251

Pulmonary Langerhans’ cell histiocytosis following autologous haemopoietic progenitor cell transplantation N.

Soler,

Letters

J. A.

Barber&,

to the

J. Ramirez,

M.

Batlle,

C.

Rozman

& R.

Rodriguez-Roisin

1252

Editor

Survival experience of the population needing hospital treatment for asthma or COPD at the age of 50-54 years 0.

M.

1256

P. Jolobe

Careful consideration needed with diagnoses of heart disease in COPD patients T. Keistinen

I,

& T. Tuuponen

1256

Number

11 November

Topical Are

1998

Review

anti-oxidant

and anti-inflammatory

treatments

effective

C. P. van Schayck, P. N. R. Dekhuijzen, W. C. L. A. van Herwaarden & C. van Wee1 ,:*:vii “?mm”‘# !I$ ma17Tmm,m “W la, -“-3mm-na.pWla * ~~~~~~~~~~~~~~~~

Original M.

patients

in general

Roberts,

J.

practice

Franklin,

with

A.

COPD

O’Neill,

in different

subgroups

J. Gorge@,

P. M.

of COPD? van

Pneumothorax

in active

J. Blanco-Perez,

J. Molema,

M.

The management

Prospective

asthma en,

lung

Asthma

and allergy

H.

of pulmonary

A. J. Simpson, B. r”Fmm~mFs!wtT% -Pmrminmv

resurgence

, S. M. Alcock ??a-f-~~P~mw’:~,-~~

of self-reported

aitinen, m~~m”li”.x

tuberculosis

systemic

J. Domagata-Kulawik,

G.

M.

requirement

L.

Hanley

using

& J.

pulse

oximetry 1265

Edwards

of an old complication?

J.

in subjects

in adults

sclerosis:

Hoser,

Study:

&

and their

notified

predicts

mortality

during

the first

10 years

family

members

volunteering

for gene mapping

in Scotland

studies

!EWT%?lZWmW

in 1993 89

F. Sudlow & A. G. Leitch .Jwm!!tE m-wm-~ ;I”-l?fc%wE?T

comparison

A.

best function

Prescott

J. Kere & T. Laitinen ~ml~.zvmaxEm~hg”: stm~?‘n~-rPwTr, ~~“~~~~~,~~~~~~~~ I- _

att, S. H. Heald, M. Tz rn!am“~l”-~F”rr+ji~~~,‘~‘~~~~

diseas

oxygen

J. Ide,

Piiieiro-Amigo, R. Rota-Serrano, R. lzquierdo & J. Abal-Arca TV”.~d4~“xs”,~,s1”~~~~~‘~,~~~~~~~ +m%s-La.Tplw%wwPm.* ‘FE-a*I”‘“~~~S,~.~?~,~~~~~~‘~~~~ Y . ,,,

M

P. Kauppi, L. A. ! 3&mmJ-vLlwWiiw Tw?p za”‘ir”

domiciliary

P. L. Roberts,

:: qxwB’Tq 732 ~‘sg”s!Frw~~p:p ‘WV3 _ ‘ICIE I ‘“rr-wmwz W’MGEm’?* 3”~‘Fmtl~~~~~~~~~~~~~~~

tuberculosis:

Bordbn,

and Northallerton

6. K. C i’m’mrw Van?

Verification

pulmonary

J.

The Darlington

of BALF

Doboszyhska,

J.

mm

lymphocyte Kawiak

& W.

1295

Droszcz

C’!&‘,LCi’@r” a “~liprs~~~‘“!p!B” 3 m,n2 /‘I*.‘iqrr.3 85%%&~w#‘i-I* “21yp?il’~xwmlr “Fl’X p:;cr3nT,~*?“~ T,P”I-ai.n~.Fy-r’~~~.~M~~-i-‘~~-FtX”:,l~’ = ,,a i

Short

A hypothesis

Grunsven,

m”~-Tr”w-slm

for long term

R.

3 r 11 E-3~‘WPB, tt-- IT QZE- wrz t-z ‘I”fbP~~~%“,~~.*1114‘:‘

Interstitial

M.

Articles

Screening C.

J.

IXzaF

Report 1302

A.1

Number

12 December

Original Genetic

Articles

polymorphism

H. Tomita,

“v-v

S.

of the angiotensin-converting R.

SatO,

Matsuda,

N.

enzyme

Ogisu,

T. Mori,

(ACE)

in asthmatic

T. Niimi

patients

& S. Shimizu

1305 ,lFw” -““i?“r-P11vil’? ‘I;:*.a’i - m- ‘“-7,x wv”~**r2 *” 1p’sz ivm@

4w “T”-n wr;inrln%9-T **81*?i‘V”‘-B-m?8wa *‘Tms”*kT,‘~T”B7pT~“lp~“‘pm”1”qy-rrq“6-aT1Q”~ mxrmw”““i

Non-invasive J.-P.

1998

home

ventilation

Janssens,

in patients

E. Cicotti,

J.-W.

over 75 years Fitting

of age: tolerance,

compliance,

of severity

of long-standing

congestive

on quality

of life 1311

:p ~-hww’*lli s&qw5 zt+/‘B,‘liu~“ll~~,~~~~-~‘~~,~,,~~,‘~,!,~~’.~~~,~~j Tw* =m”qTggo%~>-si.==‘,a-xrviP~m!‘l&“:.Yz‘T “F ~blfW~~ Effects

and impact

& T. Rochat

heart

failure

on pulmonary

1 ~!P~mR~wL~-m

Ew*r *wrwm;U”e ‘rc!m Ct”FI 41’

function

I. Dimopoulou, M. Daganou, 0. K. Tsintzas & G. E. Tzelepis wa”iB ,vxPmi “FTmx?“‘F^“W -2,W” 8,f-‘-a ‘“ipm?‘li (f-7a7 i”T“prpiv%“q,~~:~@ ix T-w”m~~ ‘: *-‘1”“-* Iri- -,g-qppibw ry ‘prmxywmm‘ir Z3r.‘“1,G*~~lxiixsi‘~%~m2lys 3

Different

expression

I. StN%

H.

of integrins

Pokornd,

by mononuclear

L. Zheng,

J.

phagocytes

Guzman

&

in peripheral

Effects

of hypoxia Skwarski,

M.

on renal D.

hormonal

Morrison,

balance A.

Barratt,

in normal M.

and bronchoalveolar

lavage

fluid 1326

“;‘~rF%‘?B,:,“+?s-,1,8 ]‘+‘!w:x’* 1711?1 .*: p i,?i’?l”a”~- “i ) =*“2”‘:: :‘: I M”tMIT1)*ll,&“y- ?lua.gx”“~*r-l

K.

blood

U. Costabel

Lee

?rm?%.ammP “w’~:PwrsPn~i~-.“-“,xT%r?3m~~v~ wmll ~?i~~.~~~“l7r”Qn~,,l-~~~~~,~

subjects & W.

a ri*r ,qli- I W”B s s,; ‘,U”“n--wqyi7myw*?@;8y:e*qm 7: zt”*??,,,*b,a “p’* g,~se~7jj _ I__

and in patients MacNee

r:s-: ‘P~“~En!mw~X

with

COPD

Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden P. Montnemery, & C.-G. LBfdahl

E. Adelroth,

K.

Heuman,

A.

Johannisson,

S.-A.

Johansson,

L.-H.

van

B.

Lundback

1337

A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced J. A.

Lindholm,

Noord,

J. J. Smeets

bronchoconstriction 1346

& F. P. V. Maesen

Asthma-related prescribing patterns with four different corticosteroid inhaler devices G.

D.

Frost,

A.

Penrose,

J.

Hall

2% D.

1352

I. MacKenzie

88

Effect of single doses of inhaled lignocaine on FEV, and bronchial reactivity in asthma T. W.

Harrison

Case

& A.

1359

E. Tattersfield

Reports

Pulmonary adenomatoid malformation D.

Hellmuth,

J. C.

Glerant,

presenting as unilobar cysts in an adult

H. Sevestre,

A.

Remond

1364 L

& V. Jounieaux

Hypersensitivity pneumonitis probably caused by cyclosporine. A case report

Alglucerase treatment of type 1 Gaucher disease with pulmonary involvement 1370 1373

Supplement

A June

1998

Foreword R.

1

Dahl

Improved delivery of inhaled steroids to the large and small airways C.

L.

3 “II

Leach

Effect of changing the fine particle mass of inhaled beclomethasone dipropionate J. P. Seale

& L.

on intrapulmonary

deposition and pharmacokinetics 9

I. Harrison

_i

Efficacy of chlorofluorocarbon-free moderate asthma

beclomethasone dipropionate

400 ug day -r delivered as an extrafine aerosol in adults with 17

Hydrofiuoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose

P. J. Thompson, D. Donnell

R. J.

Davies,

W.

F. young,

A.

B. Grossman

&

Supplement

B July 1998

Subject Index Editorials, Letters to the Editor, Case Reports and Short Reports are indicated by (E), (L), (CR) and (SR) after the page numbers, respectively. S.A. = Supplement A; S.B. = Supplement B :I A-a gradient value in asthma, bronchoalveolar lavage effects on 191-7 N-acetylcysteine characterization in anti-oxidant therapy 609-23 inhibition of IL-la-induced IL-8 secretion by bronchial epithelial cells 512-15 acetylsalicylic acid-induced asthma, inhalation challenge 378-84 acupuncture in treatment of stable asthma 1143-5 adenoma, pleomorphic, and severe tracheal obstruction 889291 (CR) adrenal’ function, effects of beclomethasone dipropionate compared with budesonide (S.B.) 2-45 adult respiratory distresssyndrome, idiopathic bronchiolitis ob;literans with pneumonia 884-6 (CR) aerosol, hypo-osmolar, induction of hyperventilation in chronic non-asthmatic rhinitics 9-13 air pollution and asthma-related emergency visits, neural network study of relationship between 1199-202 airways pon-adrenergic, non-cholinergic function 461-6 obstruction, chronic upper, pulmonary edema following 1174-6 (CR) responsiveness,effect of influenza vaccination in asthma 1010-l 1 see also chronic obstructive airways disease; obstructive airways disease; peripheral airways alglucerase treatment of type 1 Gaucher disease with pulmonary involvement 1370-2 (CR) allergen exposure, low-dose repeated, to induce experimental exacerbation of asthma 1223-30 allergic bronchopulmonary aspergillosis therapy with itraconazole 118-19 CR) allergic rhinitis effect of topical steroids on nasal nitric oxide production 558-61 methacholine response characteristics 88-94 allergy in childhood, effect of socioeconomic status, birth order and maternal smoking on 1237-44 self-reported, gene mapping in families 1281-8 type 1, and asthma in Swedish children 316-24 alpha-1-antitrypsin deficiency national registry in Spain 118l-7 PiSZ, geographical distribution in Europe 361-77 risk factor in pulmonary emphysema 241-5 alveolar compartment non-involvement in inflammatory response in non-small cell lung cancer 76-83 alveolar macrophages budesonide and terbutaline effects on phagocytosis 162-6 in sarcoidosis 126-39 smoking and interleukin-8 secretion by 922-7 alveolitis evaluation by IL-8 in BAL cells in idiopathic pulmonary fibrosis 33844 parasitic l-3

ambroxol characterization in anti-oxidant therapy 609-23 amyloidosis, reactive, in Mycobacterium simiae pulmonary infection 1234 (CR) anaesthesia local, pulse oximetry at fibreoptic bronchoscopy 532-7 and sedation practice in coronary artery bypass surgery, ICU and hospital stay length and 1066-70 angiotensin-converting enzyme genetic polymorphism in asthma 1305-10 anti-inflammatory effect in COPD subgroups 1259-64 treatment effect on bronchial asthma 547-9 anti-Jo-l antibodies, pulmonary vasculitis with 986-8 (CR) anti-oxidant therapy 609-23 effect in COPD subgroups 1259-64 antibiotics effect on lung mucociliary clearance during COPD exacerbation 442-7 arterial blood gases during dialysis in pressure support ventilation 53440 asbestos pleural disease, benign, finger clubbing in 691-2 (SW aspergillosis allergic bronchopulmonary, therapy with itraconazole 118-19 pulmonary, in insulin-dependent diabetic 972-5 (CR) Assesspeak flow meter 505-l 1 asthma ACE genetic polymorphism 1305-10 acute childhood, prednisolone in 541-6 acute severe, treated by mechanical ventilation 716-21 ASA-induced, inhalation challenge 378-84 beclomethasone dipropionate comparison with budesonide (S.B.) 2-45 delivery improvement with hydrofluoroalkane-134a (S.A.) 3-39 best function prediction of mortality 1274-80 beta,-agonists in dry powder inhaler 167-72 bronchial, diffuse pulmonary ossification and recurrent spontaneous pneumothorax 887-9 (CR) epidemiology in Turkey 792-3 (L) nasal inflammation and anti-inflammation treatment effects 547-9 bronchoalveolar lavage effects on PaO,, A-a gradient value and bronchoconstriction 191-7 bronchoconstriction in relation to methacholine bronchial responsivenessin 308-l 5 budesonide as nebulizer suspension vs metered dose inhaler 44-49 once-daily 421-5 cardiorespiratory response to submaximal exercise following salbutamol and salmeterol 1053-8 in children, salmeterol vs ‘as required’ salbutamol 292-9 chronic severe, peripheral airways obstruction on CT 448-53 clinic, nurse-run 26447 corticosteroids pharmacology 385-94

diagnosis, rapid dosimetric methacholine challenge 32-39 in elderly 513-7 evaluation of electronic hand-held spirometer 117780 exercise-induced, gastro-oesophageal reflux and 1071-5 experimental exacerbation following low-dose repeated allergen exposure 1223-30 fluticasone propionate therapy 95-104 follow-up rates following casualty attendance, hospitalprimary care communication and 289-91 formoterol vs salbutamol onset of action in reversing methacholine-induced bronchoconstriction 1346651 gas compression profile during forced expiration in 173-7 guidelines 1046652 health status measurement 1207-14 home nebulizers for adults 624-7 hospitalisation rates in Black and ethnic minority communities 642-8 survival of middle-age patients 1256 (L) influenza vaccination effect on airway responsiveness in 1010~11 inhaler comparison 105510, 11 l-17 intensive vs conventional patient education and supervision for self-management 300-7 leukotriene antagonism in 7955809 lignocaine inhalation effect on FEV, and bronchial reactivity in 1359-63 long-term therapy with salmeterol vs slow-release theophylline 683-90 methacholine response characteristics 88-94 nebulizer therapy at home 1000-2 non-adrenergic, non-cholinergic function of airways I_ 461-6 occupation, leukocyte counts in sputum 550-7 parallels with parasitic alveolitis l-3 pulmonary function and symptoms 849-57 recent-onset, work ability 729-34 -related emergency visits and air pollution, neural network study of relationship between 11999202 -related prescribing patterns with corticosteroid inhaler devices 1352-8 salbutamol via Turbohaler vs metered-dose inhaler in 325-30 salmeterol trials 777-82 , salmeterol vs theophylline 256-63 salmeterol xinafoate 13024 (SR) selfireported, gene mapping in families 1281-8 self-treatment guidelines for adults 668-75 severity marker relationship to exhaled nitric oxide 908-13 stable, acupuncture treatment 1143-5 steroid-dependent, management with methotrexate 1059-65 survival in hospitalized population 568-72 symptoms, ketotifen vs disodium cromoglycate and beclomethasone dipropionate effects on 942-50 in Turkish children 203-7 in young adulthood 100339 time trends and seasonal variation in tropical Singapore 345-50 (SR) type-l allergy and related condition in Swedish children 316-24 beclomethasone dipropionate comparison with budesonide

(S.B.) 245

delivery improvement with hydrofluoroalkane-134a (S.A.) 3-39 vs ketotifen and disodium cromoglycate efIects on bronchial mucosa and asthma symptoms 942-50 beta,-agonists in dry powder inhaler for acute asthma 167-72 BIPAP device for obstructive sleep apnoea syndrome 820-7 birth order and maternal smoking effect on childhood allergy 123744 blindness from bronchial artery embolization 983-6 (CR) blood eosinophil and monocyte counts reiated to smoking and lung function 63-69 gases in non-smoking women with chronic liver disease 57-62 transcutaneous monitoring 584-7 bone, effects of beclomethasone dipropionate comparison with budesonide (S.B.) 2245 Book Reviews Clinical and biological basis of lung cancer prevention 1373 Peak flow nzeasurenzent. An illustrated guide 365 Breathe Right@ effects on snoring 107668 breathing, sleep-disordered, comparison in Asians and Caucasians 843-8 breathlessness in COPD; salmeterol vs ipratropium bromide effects on 1116-21 British Asthma Guidelines 1046-52 bromocriptine, pleuropulmonary disease as side-effect of treatment with 11724 (CR) bronchial artery embolization, cortical blindness from 983-6 (CR) bronchial aspirates and transbronchial biopsies, PCR for diagnosis of smear-negative pulmonary TB 815-19 carcinoma: bronchoscopy and audit standards 11 lo-15 epithelial cells, glucocorticoid receptor mRNA levels in COPD, role of glucocorticoids 1102-9 N-acetylcystein inhibition of IL-la-induced IL-8 secretion by 512-15 epithelium, neutrophils infiltrating in COPD 863370 hyperreactivity related to nitric oxide exhalation 908813 in Sweden 480-7 without specific response to isocyanate in isocyanateinduced asthma 109338 metastases in chondroblastic osteosarcoma 786-8 (CR) mucosa, ketotifen vs disodium cromoglycate and beclomethasone dipropionate effects on 942-50 papilloma, solitary columnar 878-9 (CR) reactivity in asthma, lignocaine inhalation effect on 1359-63 bronchiolitis obliterans, idiopathic, with pneumonia in adult respiratory distress syndrome 884-6 (CR) bronchitic symptoms, obstructive sleep apnoea syndrome symptoms related to 283-8 bronchitis acute, von Willebrand factor antigen plasma levels 395400 chronic, antibiotic choice and dosage regimen for exacerbations 8955901 bronchoalveolar lavage cells, in eosinophilic pneumonia 743-9 interleukin-8 expression to evaluate alveolitis in idiopathic pulmonary fibrosis 338-44 lavage effects on PaO,, A-a gradient value and bronchoconstriction in asthma 191-7

fluid, hepatocyte growth factor measurement in pulmonary fibrosis 273-8 fluid, integrin expressions by mononuclear phagocytes in 1326-30 fluid, in lung cancer, cytokine fragment 19 as diagnostic marker in 766-71 fluid, lymphocyte phenotype compared to DLCO impairment in systemic sclerosis 1295301 T cell receptor subsets of lymphocytes in pulmonary TB 408-14 bronchoconstriction in asthma, bronchoalveolar lavage effects on 191-7 methacholine-induced, salbutamol vs formoterol onset of action in reversing 1346-51 in relation to methacholine bronchial responsiveness in asthma 308-15 bronchodilation prediction and salbutamol early reversibility after salmeterol in COPD 1012-16 broncholithiasis 963-5 (CR) bronchoscopy for bronchial carcinoma and audit standards 11lo-15 changes in oxygen saturation and transcutaneous carbon dioxide and oxygen levels during 73942 fibreoptic, for diagnosis of smear-negative pulmonary TB 815-19 lignocaine and monoethylglycinexylidide levels during 4043 pulse oximetry in local anaesthesia 532-7 budesonide in asthma, nebulizer suspension vs metered dose inhaler 4449 comparison with beclomethasone dipropionate (S.B.) 245 effects on phagocytosis in alveolar macrophages 162-6 nebulized, vs fluticasone propionate delivery via inhaler and Volumatic 11l-17 once-daily in asthma 421-5 Burkholderia cepacia transmission and prevalence in cystic fibrosis 178-83 C-reactive protein measurements in COPD 6647 Candida albicans, pulmonary mycetoma from 1079980 (CR) carbon monoxide level measurement with single-breath transfer factor 628-32 carcinoid, thymic, with mutinous stroma 880-J (C’R) cardiac sarcoidosis, MRI imaging 697-9 (CR) surgery, positive end-expiratory pressure effect 858-62 cardiorespiratory response to submaximal exercise following salbutamol and salmeterol in asthma 1053-8 cat, effect on lung function in primary school children 928835 cataract formation, effects of beclomethasone dipropionate comparison with budesonide (S.B.) 245 CD4 lymphocytopenia and meningitis with pulmonary cryptococcoma in HIV-negative patient 120-2 (CR) CD4’ T-lymphocytopenia, miliary TB causing acute respiratory failure in 977-9 (CR) cefamandol, early transition to oral therapy in communityacquired pneumonia 1032-9 chest CT scans in lung endometriosis 87667 (CR) radiography and TB case-finding in Australia 198-202 tube, curved 633-7

cholesterol levels to distinguish transudates from exudates 762-5 chronic obstructive pulmonary disease (COPD) anti-oxidant and anti-inflammatory effects in subgroups 1259-64 C-reactive protein measurements 6647 corticosteroid treatment during oxygen therapy 50-56 EUROSCOP study 457-72 exacerbation, antibiotics effect on lung mucociliary clearance during 442-7 exercisetest duration and dyspnea recovery time, effects of oxygen breathing and repeat testing 735-8 training and recovery after exacerbation 1191-8 Fas levels 993-9 FEV, value in screening for PaO, ~7.3 kPa in patients qualifying for long term 0, therapy 1122-6 glucocorticoid receptor mRNA levels in bronchial epithelial cells, effect of glucocorticoids 1102-9 heart disease and 125667 (L) hospitalisation, survival of middle-age patients 1256 (L) hypoxia effect on renal hormonal balance in 1331-6 nebulizer therapy at home 1000-2 neutrophils infiltrating bronchial epithelium in 863370 NPPV and haemodynamic responses 331-7 oral corticosteroid effects on bronchodilator responses 279-82 outcome following nocturnal non-invasive mechanical ventilation 1215-22 predicting cognitive decline 527-33 pulmonary function threshold for distinguishing ventilatory- and nonventilatory-limited patients 1245550 quality of life correlated with lung and muscle function 221-7 in elderly 1231-6 salbutamol early reversibility and bronchodilation prediction after salmeterol in 1012-16 salmeterol vs ipratropium bromide effects on exercise performance and breathlessnessin 1116-21 vs oxitropium bromide as bronchodilators 354-7 (SR) screening with pulse oximetry for long-term domiciliary oxygen need 1265-8 single breath vs re-breathing 7X0 18-24 subjective fatigue and physiological variables 676-82 survival in hospitalized population 568-72 tension-time index of inspiratory muscles 828835 time course of respiratory decompensation 93641 ventilation in ICU outcome 156661 vital prognosis following hospitalization 772-6 cognitive decline prediction in COPD 527-33 congestive heart failure effect on pulmonary function 1321-5 cortical blindness from bronchial artery embolization 983-6 (CR) corticosteroid inhaler devices, asthma-related prescribing patterns with 1352-8 oral, effects on bronchodilator responses in COPD 279-82 pharmacology 385-94 treatment in COPD during oxygen therapy 50-56 cough, persistent, prescribing for 638-41 CPAP therapy failure in obstructive sleep apnoea syndrome 208-15 Cushing’s disease and TB 604-6 (CR)

INDEX

cyclosporin A effect on inflammatory cytokine production by alveolar macrophages 722-8 cystic fibrosis Buvklzolderia cepacia transmission and prevalence 178-83 diabetic retinopathy in 871-2 epithelial cell damage from neutrophil-derived proteases in sputum 233340 hypomagnesaemic tetany from i.v. tobramycin in 6024 (CR) lobectomy in 695-7 (CR) nasal intermittent positive pressure ventilation 523-6 Nottingham Health Profile scores 268872 Xanthomonas maltophila respiratory infection therapy in 3634 (CR) cytokine fragment 19 as diagnostic marker in bronchoalveolar lavage fluid in lung cancer 766-71 network in sarcoidosis 126-39 production by alveolar macrophages, cyclosporin A effect 722-8 pro-inflammatory, compartmentalization in tuberculous pleurisy 14-17 response, effect of hyperoxia 951-60 dermatomyositis and small cell lung cancer of lung 601-2 (CR) response to chemotherapy for non-small cell lung cancer 788-90(CR) diabetes, pulmonary aspergillosis and 972-5 (CR) diabetic retinopathy in cystic fibrosis 871-2 diaphragm shortening during hypercapnia in rats 48 Diskus vs Turbuhaler@ 105510 disodium cromoglycate vs ketotifen and beclomethasone dipropionate effects on bronchial mucosa and asthma symptoms 942-50 DLCO impairment compared to BALF lymphocyte phenotype in systemic sclerosis 1295-301 dyspnea recovery time following exercise testing in COPD, effects of oxygen breathing and repeat testing 735-8 ECG

changes in obstructive sleep apnoea syndrome 25-27 electric baseboard heating effect on lung function in primary school children 928-35 emphysema, lung volume reduction for, lung function and quality of life following increased elastic recoil after 653-8 empyema, salmonella, following splenic biopsy 968-9 (CR) endobronchial non-Hodgkin’s lymphoma 975-7 (CR) secondaries occurrence 599-600 (SR) eosinophil counts related to smoking and lung function 63-69 epithelial cell damage from neutrophil-derived proteases in cystic fibrosis sputum 23340 in sarcoidosis 126-39 EUROSOPC study on COPD 467-72 exercise -induced asthma, gastro-oesophageal reflux and 1071-5 performance in COPD, salmeterol vs ipratropium bromide effects on 1116-21 pulmonary rehabilitation programme effect on 1146654

submaximal, cardiorespiratory response in asthma following salbutamol and salmeterol 1053-X test duration and dyspnea recovery time in COPD, effects of oxygen breathing and repeat testing 735-8 training and recovery in COPD after exacerbation 1191-8 Fas levels in COPD 993-9 fatigue, subjective, in COPD 676-82 Felty’s syndrome, pulmonary veno-occlusive disease complicating 1089-91 (CR) FEV, value in COPD screening for PaO, ~7.3 kPa in patients qualifying for long term 0, therapy 1122-6 fibrosis in sarcoidosis 140-9 finger clubbing in malignant mesothelioma and benign asbestos pleural disease 691-2 (SR) fluticasone propionate outcomes and cost-effectiveness audit 351-3 (SR) therapy in asthma 955104 delivery via inhaler and Vdlumatic vs nebulized budesonide 111-17 forced spirometry, prediction equations in European populations 401-7 formoterol efficacy in elderly with reversible obstructive airways disease 562-7 inhalation, onset and duration of action of single doses 1017-21 vs salbutamol onset of action in reversing methacholineinduced bronchoconstriction 1346651 vs salmeterol in reversible obstructive airways disease 83642 free radicals 609-23 gas compression profile during forced expiration in asthma and health 173-7 gastro-oesophageal reflux and exercise-induced asthma 1071-5 with haemoptysis and carinal erythematous lesion 1251-2 (CR) Gaucher disease, type 1: with pulmonary involvement, alglucerase treatment 1370-2 (CR) gene mapping in families self-reporting asthma and allergy 1281-8 genetic polymorphism in asthma, ACE 1305-10 glucocorticoid in asthma 385-94 receptor mRNA levels in bronchial epithelial cells in COPD, effect of glucocorticoids 110229 granulocyte transit time through lung, bimodal, deconvolution analysis 1163-6 (SC) growth in children with asthma, effects of beclomethasone dipropionate comparison with budesonide (S.B.) 2245 haemopoietic progenitor cell transplantation, puhnonary Langerhans’ cell histiocytosis following autologous 1253-5 (CR) haemoptysis with gastroesophageal reflux and carinal erythematous lesion 1251-2 (CR) haemosiderosis, idiopathic pulmonary 902-7 health habits and illness behaviour 150-5 heart disease and COPD 1256-7 (L) failure, congestive, nocturnal oxygen and hypercapnic ventilatory response 426-3 1

IN~ZJEX

hepatocyte growth factor measurement in serum and bronchoalveolar lavage fluid in pulmonary fibrosis 273-8 histiocytosis, pulmonary Langerhans’ cell, following autologous haemopoietic progenitor cell transplantation 1253L5 (CR) HLA-DQBl and HLA-DPBl genotypes in familial sarcoidosis 649-52 hospital stay following coronary artery bypass surgery, anaesthetic practice and 1066-70 house dust mite exposure evaluation 1099-101 swine, and levels of IL- l/3 and IL- 1 receptor antagonist in _,- peripheral blood 1022-7 hydrofluoroalkane-134a, delivery improvement of beclomethrisone dipropionate (S.A.) 3-39 hypercapnia in rats, diaphragm shortening and intrathoracic pressure during 4-8 hypercapnic respiratory failure, nasal intermittent positive pressure ventilation 523-6 hypercapnic vehtilatory response in congestive heart failure 426-3 1 hypersensitivity pneumonitis caused by cyclosporine 1368-70 (CR) hypomagnesaemic tetany from iv. tobramycin in cystic fibrosis 602-4 (CR) hypoxia effect on macrophage cytokine response 951-60 on renal hormonal balance in COPD 1331-6 ICU stay following coronary artery bypass surgery, anaesthetic practice and 1066-70 ventilation outcome in COPD 156-61 illness behaviour, health habits and 150-5 inflammatory bowel disease,lung function 516-22 influenza vaccination effect on airway responsiveness in asthma 1010-l 1 inhaler comparison 105-10, 11l-17 new powder, salbutamol bronchoprotection 578-83 integrin expressions by mononuclear phagocytes in peripheral blood and BALF 1326-30 interleukin-lp and receptor antagonist levels in peripheral blood from swine house dust inhalation 1022-7 interleukin-8 expression in BAL cells to evaluate alveolitis in idiopathic pulmonary fibrosis 338-44 secretion by alveolar macrophages, smoking and 922-7 by bronchial epithelial cells, N-acetylcystein inhibition of IL-la-induced 512-15 interstitial lung piseases,~53 protein overexpression 184-90 intrathoracic pressure during hypercapnia in rats 4-8 IPPV in cystic fibrosis and hypercapnic respiratory failure 523-6 ipratropium bromide vs salmeterol effects Zm exercise performance and breathlessnessin COPD 1116-21 isocyanate-induced asthma, bronchial hyperresponsiveness without specific response to isocyanate in 1093-8 itraconazole therapy of allergic bronchopulmonary aspergillosis 118-19 Jo-l syndrome, pulmonary fibrosis in polymyositis in 1167-9 (CR)

ketotifen vs disodium cromoglycate and beclomethasone dipropionate effects on bronchial mucosa and asthma symptoms 942-50 Kviem-Siltbach test 126-39 lactate dehydrogenase to distinguish transudates from exudates 762-5 Langerhans’ cell histiocytosis, pulmonary, following autologous haemopoietic progenitor cell transplantation 1253-5 (CR) leukocyte counts in sputum in occupational asthma 550-7 leukotriene antagonism in asthma and rhinitis,795-809 D,/E, receptor antagonist for diffuse panbronchiolitis 1084-6 (CR) Light’s criteria vs biochemical parameters to distinguish transudates from exudates 762-5 lignocaine inhalation effect on FEV, and bronchial reactivity in asthma 1359-63 levels during fibreoptic bronchoscopy in local anaesthesia 4043 liver disease, chronic, blood gases in non-smoking women 57-72 lobectomy in cystic fibrosis 695-7 (CR) lung abscesswith squamous epithelial lining 790-l (CR) cancer, cytokine fragment 19 as diagnostic marker in bronchoalveolar lavage fluid 766-71 non small-cell, inflammatory response 76-83 with malignant effusion, intrapleural paclitaxel for 473-9 response of dermatomyositis to chemotherapy for 788-90 (CR) small cell, dermatomyositis and 601-2 (CR) deconvolution analysis of bimodal granulocyte transit time 1163-6 (SC) disease hospitalization in early childhood 1003-9 interstitial, ~53 protein overexpression 184-90 in systemic sclerosis 1295-301 obstructive, prevalence in Sweden 133745 see also chronic obstructive lung disease (COPD) endometriosis, CT scans 876-7 (CR) function, eosinophil and monocyte counts related to smoking and 63-69 impairment, obstructive sleep apnoea syndrome symptoms related to 283-8 improvement following increased elastic recoil after lung volume reduction surgery in emphysema 653-8 in inflammatory bowel disease 516-22 lignocaine inhalation effect on FEV, and bronchial reactivity in asthma 1359-63 measurements, prediction equations in European populations 401-7 of primary school children, domestic factors and 928-35 quality of life in COPD correlation 221-7 volumes, plethysmographic, prediction equations 454-60 reduction surgery in emphysema, improved lung function and quality of life following increased elastic recoil after 653-8 lymphocyte phenotype in BALF compared to DLCO impairment in systemic sclerosis 1295-301

lymphoma, large cell intravascular, pulmonary presentation of1087-9 (CR) lymphomatoid granulomatosis mimicking sarcoidosis 966-8 (CR) macrolide antibiotics for diffuse panbronchiolitis 1084-6 (CR) macrophage alveolar, cyclosporin A effect on inflammatory cytokine production by 722-8 smoking and interleukin-8 secretion by 92227 budesonide and terbutaline effects on phagocytosis in 162-6 cytokine response, effect of hyperoxia 951-60 phenotype in sputum, smoking and 415-20 in sarcoidosis 126-39 malignant mesothelioma, finger clubbing 691-2 (SR) MDPI inhaler, salbutamol bronchoprotection 578-83 mechanical ventilation for acute severe asthma mediastinal nonseminomatous germ cell tumour 882-4 (CR) meningitis and CD4 lymphocytopenia with pulmonary cryptococcoma in HIV-negative patient 120-2 (CR) methacholine bronchial responsivenessin relation to cold air inhalation and exercise-induced bronchoconstriction in asthma 308-15 challenge in asthma diagnostics 32-39 chloride, stability in solution, effect of pH 588-92 -induced bronchoconstriction, salbutamol vs formoterol onset of action in reversing 1346-51 response characteristics in asthma, allergic rhinitis and healthy subjects 88-94 methotrexate, management of steroid-dependent asthma 1059965 Mini-Wright peak flow meter 505-l 1 monocyte counts related to smoking and lung function 63-69 monoethylglycinexylidide levels during fibreoptic bronchoscopy in local anaesthesia 4043 mononuclear phagocytes integrin expressions in peripheral blood and BALF 1326630 Morgan Transflow system 628-32 mucociliary clearance, antibiotics effects during OPCD exacerbation 44227 muscle function, quality of life in COPD correlation 221-7 mycetoma, pulmonary, from Can&a albicans 1079-80 (CR) Mycobacterium simiae pulmonary infection, reactive amyloidosis in 123-4 (CR) Mycobacterium vaccae safety and outcome measures 597-8 (SR) nasal continuous positive airway pressure for obstructive sleep apnoea syndrome 820-7 treatment interruption in obstructive sleep apnoea 28-3 1 nasal inflammation effect on bronchial asthma 547-9 nasal intermittent positive pressure ventilation in cystic fibrosis and hypercapnic respiratory failure 523-6 nebulizer therapy at home 1000-2 in adult asthma 62447 neural network study of relationship between air pollution and asthma-related emergency visits 11999202

neutrophil -derived proteases in cystic fibrosis sputum, damage to epithelial cells 233-40 infiltrating bronchial epithelium in COPD 863-70 nitric oxide exhaled, relationship to markers of asthma severity 908-13 production, nasal, in perennial allergic rhinitis, effect of topical steroids 558-61 and respiratory system 701-15 Nocaudia astevoides drug resistance in pulmonary nocardiosis 873-5 (CR) non-Hodgkin’s lymphoma, endobronchial975-7 (CR) obstructive airways disease reversible, efficacy of formoterol in elderly 562-7 formoterol vs salmeterol in 836-42 see also chronic obstructive airways disease obstructive sleep apnoea syndrome ambulatory diurnal sleep recording 216-20 appearance of central apnoea following auto-CPAP 891-3 (CR) CPAP therapy failure in 208-15 ECG changes 25-27 nasal continuous positive airway pressure treatment interruption 28-3 1 hypopnoea number effect on therapy 1028-31 symptoms related to bronchitic symptoms or lung function impairment 283-8 osteosarcoma, chondroblastic, endobronchial metastases in 786-8 (CR) oxitropium bromide effects on bronchodilator responses in COPD 279982 vs salmeterol as bronchodilators in COPD 354-7 (SR) oxygen breathing effects, exercise test duration and dyspnea recovery time in COPD 735-8 levels during dialysis in pressure support ventilation 53440 need, COPD screening with pulse oximetry for long-term domiciliary 1265-8 saturation changes in fibreoptic bronchoscopy 739942 supply, concentrators in domiciliary situation 250-5 therapy in COPD, corticosteroid treatment during 50-56 and FEV, value in COPD screening for Pa0,<7.3 kPa 1122-6 long-term, characteristics and complaints of patients 70-75 liquid vs oxygen concentrators or compressed gas cylinders, patient characteristics 84-87 nocturnal, in congestive heart failure 426631 patient compliance improvement 1203-6 transcutaneous level changes in fibreoptic bronchoscopy 73942 p53 protein overexpression in interstitial lung diseases 184-90 paclitaxel, intrapleural, for non small-cell lung cancer with malignant effusions 473-9 panbronchiolitis: diffuse, treated with low-dose macrolide antibiotics and leukotriene D,/E, receptor antagonist 1084-6 (CR) PaO, in asthma, bronchoalveolar lavage effects on 191-7 papilloma, bronchial solitary columnar 787-9 (CR) parasitic alveolitis parallels with asthma l-3

INDEX

patient behaviour and health habits 150-5 compliance, diary compared to monitor recording 1188-90 improvement with long-term oxygen therapy following formal assessmentand training 120336 PCR for diagnosis of smear-negative pulmonary TB 8 15-19 peak flow meters compared 505-l 1 PEF diurnal variability related to nitric oxide exhalation 908-13 peripheral airways obstruction on CT in chronic severe asthma 448-53 phagocytosis in alveolar macrophages, budesonide and terbutaline effects 162-6 plethysmographic lung volumes, prediction equations 454-60 pleural biopsy vs pleuroscopy in malignant effusion or tuberculous pleurisy 488892 brushing, closed percutaneous 659-63 diseasefrom asbestos, finger clubbing in 691-2 (SR) effusion, Light’s criteria vs biochemical parameters to distinguish transudates from exudates 762-5 malignant, pleurodesis with small percutaneous catheter 593-6 use of curved chest tube drainage 633-7 mass developing following talc pleurodesis 358-9 (CR) pleurisy, tuberculous, pro-inflammatory cytokine compartmentalization 14-17 pleuropulmonary disease as side-effect of treatment with bromocriptine 11724 (CR) pneumonia bacterial, rhabdomyolysis and 359-62 (CR) community-acquired, early transition to oral antibiotic therapy 1032-9 time course of symptom resolution 113742 eosinophilic, bronchoalveolar lavage cells 743-9 Pseudomonas putida with mucoid phenotype 693-7 (CR) pneumothorax drainage with iv. catheter 961-2 (CR) persistent air leak 767-61 in pulmonary tuberculosis 1269-73 recurrent spontaneous, in bronchial asthma 887-9 (CR) spontaneous, delayed referral reduction of success in video-assisted thoracoscopy 246-9 impact on smoking behaviour in young people 1132-6 polymyositis and pulmonary fibrosis in Jo-1 syndrome 1167-9(CR) positive end-expiratory pressure effect in cardiac surgery 858862 prednisolone in acute childhood asthma 541-6 protease damage to epithelial cellsin cystic fibrosis sputum 23340 -inhibitor system Z, alpha,-antitrypsin deficiency risk in pulmonary emphysema 241-5 Pseudomonas-derived proteases in cystic fibrosis sputum, damage to epithelial cells 23340 Pseudomonas putida with mucoid phenotype, pneumonia from 69337 (CR) Pulmo-graph peak flow meter 505-l 1 pulmonary adenomatoid malformation presenting as unilobar cysts in adult 1364-7 (CR) aspergillosis in insulin-dependent diabetic 972-5 (CR)

cryptococcoma with CD4 lymphocytopenia and meningitis in HIV-negative patient 120-2 (CR) disease, domiciliary non-invasive ventilation in elderly patients 131l-20 edema following chronic upper airway obstruction 1174-6 (CR) emphysema, alpha,-antitrypsin deficiency PiSZ, risk factor in 241-5 eosinophilia, tropical, pathogenesis l-3 fibrosis, hepatocyte growth factor measurement in serum and BAL 273-8 idiopathic, interleukin-8 expression in BAL cells to evaluate alveolitis in 33844 in polymyositis with the Jo-l syndrome 1167-9 (CR) function in asthma 849-57 effect of long-standing heart failure 1321-5 laboratories re-audit 1155562 threshold for distinguishing ventilatoryand nonventilatory-limited patients with airflow obstruction 1245-50 haemosiderosis, idiopathic 902-7 infarction revealing pulmonary Takayasu’s arteritis 969-71 (CR) infection, reactive amyloidosis in 12304 (CR) infiltrates, migratory 108l-4 (CR) involvement with type 1 Gaucher disease, alglucerase treatment 1370-2 (CR) Langerhans’ cell histiocytosis following autologous haemopoietic progenitor cell transplantation 1253-5 (CR) mycetoma from Candida a&cans 1079-80 (CR) nocardiosis, drug resistance in 873-5 (CR) ossification, diffuse, in bronchial asthma 887-9 (CR) presentation of intravascular large cell lymphoma 1087-9 (CR) rehabilitation programme effect on exerciseperformance and quality of life 1146-54 tuberculosis in adults in Scotland 1289-94 vasculitis with anti-Jo-l antibodies 986-8 (CR) veno-occlusive disease complicating Felty’s syndrome 1089991 (CR) diagnosis 979-83 C(R) pulse oximetry COPD screening for long-term domiciliary oxygen need 1265-8 at fibreoptic bronchoscopy in local anaesthesia 532-7 in smokers 989-90 (L) quality of life analysis in sarcoidosis 750-6 in COPD correlated with lung and muscle function 221-7 in elderly with COPD 1231-6 improvement following increased elastic recoil after lung volume reduction surgery in emphysema 653-8 measurement in asthma 1207-14 pulmonary rehabilitation programme effect on 1146-54 re-breathing vs single breath TLC0 in COPD 18-24 renal hormonal balance in COPD, hypoxia effect on 1331-6 respiratory decompensation time course in COPD 936-41 failure, hypercapnic, secondary to sclerodermic chest wall restriction, non-invasive ventilation in 1170-2 (CR) system compliance following thoracoplasty 810-14 symptoms prevalence in Sweden 1337-45

rhabdomyolysis and bacterial pneumonia 359-62 (CR) rhinitis chronic non-asthmatic, hypo-osmolar aerosol induction of hyperventilation in 9-13 leukotriene antagonism in 7955809 salbutamol ‘as required’, vs salmeterol in asthmatic children 292-9 bronchoprotection from new powder inhaler 578-83 early reversibility and bronchodilation prediction after salmeterol in C6PD 1012-16 effects on bronchodilator responses in COPD 279-82 in Turbuhalera for acute asthma 167-72 and salmeterol in asthma, cardiorespiratory response to submaximal exercise following 1053-8 use recording on diary card compared to compliance monitor recording 1188-90 via Turbuhaler@ vs metered-dose inhaler in asthma 325-30 vs formoterol onset of action in reversing methacholineinduced bronchoconstriction 134651 salmeterol and salbutamol in asthma, cardiorespiratory response to submaximal exercise following 1053-8 early reversibility and bronchodilation prediction in COPD after 1012-16 trials in asthma 777-82 vs ‘as required’ salbutamol in asthmatic children 292-9 vs formoterol in reversible obstructive airways disease 836-42 vs ipratropium bromide effects on exercise performance and breathlessnessin COPD 1116-21 vs oxitropium bromide as bronchodilators in COPD 354-7 (SR) vs slow-release theophylline for long-term therapy in asthma 683390 vs theophylline in asthma 256663 xinafoate in asthma 1302-4 (SR) salmonella empyema following splenic biopsy 96889 (CR) sarcoidosis clinical manifestation, staging and therapy 140-9 historical perspective and immunopathogenesis 126-39 familial, HLA-DQB 1 and HLA-DPBl genotypes 649-52 quality of life analysis 750-6 recurrent venous obstruction 785-9 (CR) sclerodermic chest wall restriction: non-invasive ventilation in hypercapnic respiratory failure secondary to 1170-2 (CR) sclerosis, amyotrophic lateral, long-term mechanical ventilation 438841 serum markers for sarcoidosis 140-9 single breath transfer factor measurement 628-32 vs re-breathing TLC0 in COPD 18-24 skin changes, effects of beclomethasone dipropionate comparison with budesonide (S.B.) 245 sleep apnoea see obstructive sleep apnoea sleep -disordered breathing comparison in Asians and Caucasians 843-8 recording, diurnal ambulatory, in obstructive sleep apnoea syndrome 2 16-20 smoking behaviour, effect of pneumothorax in young people 1132-6

habits, social processesin development 150-5 eosinophil and monocyte counts related to lung function and 63-69 and interleukin-8 secretion by alveolar macrophages 92227 macrophage phenotype in sputum 415-20 by mother, socioeconomic status and birth order effect on childhood allergy 123744 passive, effect on lung function in primary school children 928-35 pulse oximetry 989-90 (L) snoring, Breathe Right@ effects on 1076-8 socioeconomic status and maternal smoking effect on childhood allergy 123744 spirometer, electronic hand-held 1177-80 spirometric measurement selection 4988504 reference equations for older adults 914-21 splenic biopsy, salmonella empyema following 968-9 (CR) ‘, I’ steroid -dependent asthma, management with methotrexate 1059-65 inhaled, improved delivery with hydrofluoroalkane-134a (S.A.) 3-8 topical, effect on nasal nitric oxide production in perennial allergic rhinitis 558-61 see also corticosteroid swine house dust and levels of IL-lp and IL-l receptor antagonist in peripheral blood 102227 systemic sclerosis,interstitial lung disease in 1295-301 T cell lymphocytopenia, CD4’, miliary TB causing acute respiratory failure in 977-9 (CR) receptor subsets of lymphocytes in bronchoalveolar lavage in pulmonary TB 408-14 in sarcoidosis 1266239 Takayasu’s arteritis, pulmonary infarction revealing 969-71 (CR) talc pleurodesis, apical pleural mass development following 35889 (CR) terbutaline effects on phagocytosis in alveolar macrophages 162-6 q.i.d. compared to formoterol b.i.d. via Turbuhaler@ 1040-5 theophylline vs salmeterol in asthma 256663 vs slow-release salmeterol for long-term therapy in asthma 683-90 thoracic gas compression profile during forced expiration in asthma and health 173-7 thoracoplasty, total respiratory system compliance 810-14 thoracoscopy results and complications 228-32 video-assisted, delayed referral reduction of successin spontaneous pneumothorax 246-9 thymic carcinoid with mutinous stroma 880-2 (CR) tobramycin, i.v., hypomagnesaemic ‘tetany in cystic fibrosis 6024 (CR) tracheal obstruction and pleomorphic adenoma 889-91 (CR) transfer factor for CO, single breath vs re-breathing, in COPD 18-24 tuberculosis case-finding in Australia, chest radiography and 198-202

INDEX

in cattle, human implications 990-l (L) contact tracing in low-incident area 1127-31 Cushing’s disease and 6046 (CR) miliary, causing acute respiratory failure in idiopathic CD4’ T-lymphocytopenia 977-9 (CR) pleurisy, pleural biopsy vs pleuroscopy 488-92 pro-inflammatory cytokine compartmentalization 14-17 pulmonary, in adults in Scotland 1289-94 pneumothorax in 1269973 radiographic spectrum 493-7 T cell receptor subsets of lymphocytes in bronchoalveolar lavage in single pleural nodule in minor fissure 783*91 (CR) smear-negative pulmonary, rapid diagnosis via fibreoptic bronchoscopy 8 15-19 Turbuhaler@ for beta,-agonists in acute asthma 167-72 low-dose formoterol b.i.d. compared to terbutaline q.i.d. via 1840-5 vs Diskus 105-10 vs metered-dose inhaler in asthma, salbutamol in 325-30

ventilation domiciliary non-invasive, in elderly patients 131l-20 during dialysis in pressure support ventilation 534-40 in ICU, outcome in COPD 156-61 long-term mechanical, in amyotrophic lateral sclerosis 438-41 nocturnal non-invasive, COPD outcome following 1215-22 non-invasive, in hypercapnic respiratory failure secondary to sclerodermic chest wall restriction 1170-2 (CR) .i Vitalograph@ 2110 evaluation 1177780 von Willebrand factor .antigen plasma levels in acute bronchitis and, normal population 395400

Wright Pocket meter 505-l 1 maltophila respiratory infection therapy in cystic fibrosis 3634 (CR)

Xanthomonas

INDEX

Author

Index

Aaron SD, Dales RE, Pham B. Management of steroiddependent asthma with methotrexate: a meta-analysis of randomized clinical trials 1059965 Abad J see Fiz JAF Abal-Arca J see Blanco-Perez J Abbey DE see McDonnell WF Abe M, Hashimoto S, Hara H. A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D,/E, receptor antagonist 10846 Abe S see Tanaka H Abel AT, Parwer S, Sanyai SC. Pulmonary mycetoma probably due to Candida albicans with complete resolution 1079-80 (CR) Abisheganaden J see Chee CBE Adalioglu G see Saraclar Y Adams JP, Conway SP, Wilson C. Hypomagnesaemic tetany associated with repeated courses of intravenous tobramycin in a patient with cystic fibrosis 602-4 (CR) Adelroth E see Montnemery P Agnew JE see Hasani A Agusti AGN see Carrera M Agusti P see Xaubet A Aharon A, Langevitz P, Maran R, Blank-Porat D, Shtrasburg S: Livneh A. Reactive amyloidosis in a patient with Mycobacterium simiae pulmonary infection 123-4 Aiolfi S see Confalonieri M Akagawa S see Shishido H Al-Ali M, Howarth PH. Nitric oxide and the respiratory system in health and disease 701-15 Eames C, Howart H. Exhaled nitric oxide: relationship to clinicophysiological markers of asthma severity 908-13 Al-Rawas OA see Carter R Alani FSS see Ormerdo LP Alanko K see Seppalb O-P Alcock SM, Mamun M, Prescott RJ, Connolly CK. Symptoms and pulmonary function in asthma 849-57 see also Connolly CK Allen DB. Effect of inhaled beclomethasone dipropionate and budesonide on growth in children with asthma 37-45 (S.B.) Alonso J see Monso E Alvarez A see Orriols R Alvarez D see ValdCs L Alvarez-Sala R see Valdes L Ambrodino N see Clini E Andersson B see Palmqvist M Andreadis D see Patakas D Andreas S, Miihlen F von zur, Stevens J, Kreuzer H. Nocturnal oxygen and hypercapnic ventilatory response in patients with congestive heart failure 426-3 1 Andreoli A see Sergi M Angelo HR see Milman N Angus R see Thomson NC Ansari S, Thomas S, Campbell IA, Furness L, Evans MR. Refined tuberculosis contact tracing in a low incidence area 1127-31 Anthi A see Michaelopoulos A

Antonelli Incaizi R, Chiappini F, Fuso L, Torrice IMP, Gemma A, Pistelli R. Predicting cognitive decline in patients with hypoxaemic COPD 527-33 Antoo JM see Rota J Anttinez J see Valdes L Antzaka C see Michalopoulos A Appleby JL see Price DB Arakawa M see Fujimori K Arends J-W see Korn SH Argyropoylou P see Patakas D Armstrong J segBrown I Asano K see Yasuda N Askgaard DS see Wilcke JTR Aslbach GPJ see Kampelmacher MJ Atherton ST see Kearney SE Atkin A see Dickinson J Atlas SJ see Metlay JP Au LY see Wong CF Aubert G see Liistro G Ayres JG see Boldy DAR Ayuso MC see Xaubet A Aznar J see Cremades MJ Azzolin NM see Baraldi E Babera JA see Soler N Bacci E see Di Franc0 A Balder B, Lindholm NB, Lliwhagen 0, Palmqvist M, Plaschke P, Tunsater A, TorCn K. Predictors of selfassessed work ability among subjects with recent onset ashtma 729-34 Ballardini L see Spanevello A Bamberga M see Sergi M Banham S see O’Reilly JF Bansai SK see Parameswaran K Bansal AS see Brown I Baraff LJ see Mower WR Baraldi E, Azzolin NM, Carra S, Dario C, Marchesini L: Zacchello F. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study 558-61 Barbara JA see Castellsague J Barb& F see Carrera M Barbera JA see Rota J; Xaubet A Barker KF see Janes SM Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short and simple instrument 1207714 Barnes NC, Hallett C, Harris TAJ. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less 95-104 Barratt A see Skwarski K Barros-Tizon JC see Miravitlles M Bartoli ML see Di Franc0 A Basran GS see O’Reilly JF Bathe M see Soler N Becklake MR see Demissie K Bedi R see Gilthorpe MS Bein G see Schiirmann M Bell D see Janes SM Bellamy D see Partridge MR

Bellone A see Confalonieri M Benstrup KE, Jensen JI, Reintoft I. Lung abscess with squamous epithelial lining 790-l (CR) Berg A von, de Blic J, la Rosa M, Kaad P-H, Moorat A. A comparison of regular salmeterol vs ‘as required’ salbutamol therapy in asthmatic children 292-9 Bertacco S see PesciA Biernacki W, Peake MD. Acupuncture in treatment of stable asthma 1143-5 Bisgaard H, Nikander K, Munch E. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics 4449 Bjijrnsson E see Norrman E Blanco-Perez J, Borden J, Pifieiro-Amigo L, Rota-Serrano R, Izquierdo R, Abal-Arca J. Pneumothorax in active pulmonary tuberculosis: resurgence of an old complication? 1269-73 Blank-Porat D see Aharon A Boe J see Nana A; Schaaning J Boldy DAR, Short PE, Cowen P, Hill FGH, Chambers DC, Ayres JG. Plasma levels of von Willebrand factor antigen in acute bronchitis and in a normal population 395400 Boman G see Norrman E Bondesson E, Friberg K, Soliman S, Liifdahl C-G. Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metereddose inhaler in patients with asthma 325-30 Boobis AR. Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide (S.B.) 2-6 Borciani N see PesciA Borden J see Blanco-Perez J Borowsky LH see Metlay JP Boudewyns A, Van de Heyning P, De Backer W. Appearance of central apnoea in a patient treated by autoCPAP for obstructive sleep apnoea 891-3 (CR) Bourke SJ see Reid DW Bouros D, Tzanakis N, Psathakis K, Patsourakis G, Rokkas T. Gastroesophageal reflux presented with haemoptysis and carinal erythematous lesion resembling in situ carcinoma 1251-2 (CR) see also Tzanakis N Bousquet J see Demoly P Boyd G see O’Reilly JF Bragonier R, Grier D, Carswell F, Cunningham S. Lobectomy in cystic fibrosis 695-7 (CR) Brambilla C see Devouassoux G Brambilla R see Thomson NC Bredin CP see Henry M Breslin EH see Breukink SO Bresnihan B see Kiely JL Breteler MHM see Wirnsberger RM Breukink SO, Strijbos JH, Koorn M, Koeter GH, Breslin EH, Schans CP van der. Relationship between subjective fatigue and physiological variables in patients with chronic obstructive pulmonary disease 676682 Britton JR see Lewis SA Bromly CL see Reid DW Brooks G see Davies B Brown I, Joyce C, Hogan PG, Armstrong J, Steele R, Bansal AS. Pulmonary vasculitis associated with antiJo-l antibodies 986-S (CR) Burchette RJ see McDonnell WF Burgos F see Castellsague J; Rota J

Burnett I see Hamid S Burris J see Pierce JD Busby HK see Murata GH Bustamante A see Miravitlles M Buurman WA see Staal-van den Brekel AJ Byrd RP, Roy TM. Rhabdomyolysis and bacterial pneumonia 359-62 Cacciani G see PesciA Calderaro F see Cazzola M Califano C see Cazzola M Callaway MP see Simpson JCG Campbell AP see Doherty MJ h Campbell IA see Ansari S Capdevila X see Hayot M Capurro M see Rodriguez MC Cargill K see Price DB Carlsen K-H, Engh G, Mark M, Schroder E. Cold air inahalation and exercise-induced bronchoconstriction in relationship to methacholine bronchial responsiveness: different patients in asthmatic children and children with other chronic lung diseases308-15 Carnevali S see Di Franc0 A Carr DH, Hibon S, Rubens M, Chung KF. Peripheral airways obstruction on high-resolution computed tomography in chronic severe asthma 448-53 Carra S see Baraldi E Carrera M, Barbe F, Agusti AGN. Does the number of hypopnoeas influence therapy in patients with obstructive sleep apnoea? 1028-31 Carrion M see Xaubet A Carswell F see Bragonier R Carter R, Al-Rawas OA, Stevenson RD, Naik SK, Wheatley DJ. The measurement of the single-breath transfer factor for carbon monoxide and its components using the Morgan Transflow system ~628-32 Casan P see Gomez J; Rota J Casas F see Miravitlles M Castellsague J, Burgos F, Sunyer J, Barbara JA, Rota J. Prediction equations for forced spirometry from European origin populations 401-7 see also Rota J Castronovo C see Sergi M Cave C see Dawson S Cayton RM see Hill AT Cazals V see Desmarquest P Cazzola M, Matera MG. Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropirate antibiotic and the dosage regimen for treating acute exacerbation of chronic bronchitis 895901 Matera MG, Di Perna F, Calderaro F, Califano C, Vinciguerra A. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease 354-7 Vinciquerra A, Di Perna F, Matera MG. Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive disease 1012-16 Cederlund K see Norman M Cetinkaya F see Saraclar Y Chadelat K see Desmarquest P Chadha D s,eeParameswaran K Chambers DC see Boldy DAR Chan CHS see Hoheisel G

INDEX

Clan CY see Wong CF Chang BC see Ho CL Charles TJ, Hariraj R. Salmonella empyema following splenic biopsy 968-9 (CR) Chatrou M see Smit HJM Chee CBE, Abisheganaden J; Yeo JKS, Lee P, Huan PYM, Poh SC, Wang YT. Persistent air-leak in spontaneous pneumothorax - clinical course and outcome 757-61 Chen Y-M see Perng R-P Cheng AFB seeWong CF Chew FT, Goh DYT, Ooi BC, Lee BW. Time trends and seasonal variation in acute childhood asthma in tropical Singapore 345-50 (SR) Chiappini F see Antonelli Incaizi R Chisholm SL, Dekker FW, Knuistingh Neven A, Petri H. Once-daily budesonide in mild asthma 421-5 Chou K-C see Perng R-P Chung KF see Carr DH; Demoly P Ciaccia A see Cogo AL Cianchetti S see Di Franc0 A Cicotti E see JanssensJ-P Clancy RL see Pierce JD Clarke SW see Hasani A Clausen JL see Rota J Clement A see Desmarquest P Clementsen P, Evald T, Grode G, Hansen M, Krag Jacobsen G, Faurschou P. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study 593-6 see also Hansen M Clerk AA see Ong KC Clini E, Sturani C, Porta R, Scarduelli C, Galavotti V, Vitacca M, Ambrodino N. Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation 1215-22 Cochrane GM see Hamid S Cogo AL, Ferrari M, Fugagnoli A, Micheletto C; Ciaccia A. Hypo-osmolar aerosol induces hyperventilation in chronic non-asthmatic rhinitis 9-13 Co11R see Monsb E Cola L see Kalyoncu AF Comet R, Domingo C, Such JJ, Ribera G, Sans J, Mar-in A. Pleuropulmonary disease as side-effect of treatment with bromocriptine 1172-4 (CR) Confalonieri M, Gazzaniga P, Gandola L, Aiolfi S, Della Porta R, Frisinghelli A: Bellone A. Haemodynamic response during initiation of non-invasive positive pressure ventilation in COPD patients with acute ventilatory failure 33 1-7 Congleton J: Hodson ME, Duncan-Skingle F. Do Nottingham Health Profile scored change over time in cystic fibrosis? 268-72 Connolly CK, Mamun M; Alcock SM, Prescott RJ. The Darlington and Northallerton Prospective Asthma Study: best function predicts mortality during the first 10 years 1274-80 see also Alcock SM Connolly MJ see Yohannes AM Conway SP see Adams JP Cooper CB see Marques-Magallanes JA Corden Z, Rees PJ. The effect of oral corticosteroids on bronchodilator responses in COPD 279-82 Corden ZM see Hamid S Cormier RA see Watson BL

Corroyer S see Desmarquest P Costabel U see Striz I Coulomb M see Devouassoux G Cowan ME see Doherty MJ Cowen P see Boldy DAR Cremades MJ, Memendez R: Pastor A: Llopis R, Aznar J. Diagnostic value of cytokeratin fragment 19 (CYFRA21-1) in bronchoalveolar lavage fluid in lung cancer 766-7 1 Crompton GK see Simpson AJ Cunniffe J see Dev D Cunningham D see Kon OM Cunningham S see Bragonier R Cuomo A see PesciA D’Souza M. Comparative review of the effects of inhaled beclomethasone dipropionate and budesonide on bone (S.B.) 24436 Daganou M see Dimopoulou I Dahl R. Foreword (S.B.) 1 see also Jensen EJ; Mygind N Dahlen B, Melillo G. Inhalation challenge in ASA-induced asthma 378-84 Dales RE see Aaron SD Darby H see Price DB Dario C see Baraldi E Davidson RN see Marshall BG Davies B, Brooks G, Devoy M. The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies 256663 Davies MG see Fitch PS Davies RJ, Stampone P, O’Connor BJ. Hydrofluoroalkane134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose (S.A.) 23-32 see also Thompson PJ Dawson S, Cave C, Pavord I, Potter JF. Transcutaneous monitoring of blood gases: is it comparable with arterialized earlobe sampling? 584-7 De Backer W see Boudewyns A de Blic J see Berg A von de Boisblanc BP see Omidvari K de Vries J see Wirnsberger RM Deguchi K see Shishido H Dekhuijzen PNR see Schayk CP van Dekker FW see Chisholm SL Deliyanni M see Michalopoulos A Della Cioppa G see Vervloet D Della Porta R see Confalonieri M Demedts MG see Nollet AS Demissie K, Ernst P, Joseph L, Becklake MR. The role of domestic factors and day-care attendance on lung function of primary school children 928-35 Demoly P, Chung KF. Pharmacology of corticosteroids 385-94 Jaffuel D, Sahla H, Bousquet J, Michel F-B, Godard P. The use of home nebulizers in adult asthma 624-7 Dente FL see Di Franc0 A Dentener MA see Staal-van den Brekel AJ Derom E see Ringdal M

INDEX

Desmarquest P, Chadelat K, Corroyer S, Cazals V, Clement A. Effect of hyperoxia on human macrophage cytokine response 95 I-60 Dev D, Wallace E, Sanakaran R, Cunniffe J, Govan JRW, Wathen CG, Emmanuel FXS. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease 664-7 Devereux G, Evans MJ, Kerr KM, Legge JS. Pulmonary veno-occlusive disease complicating Felty’s syndrome 1089-91 Devouassoux G, Pison C, Witmeyer P, Tony F, Coulomb M, Brambilla C. Pulmonary infarction revealing pulmonary Takayasu’s arteritis 969-71 (CR) Devoy M see Davies B Di Benedetto G see Vervloet D Di Franc0 A, Vagaggini B, Bacci E, Bartoli ML, Cianchetti S, Carnevali S, Dente FL, Giannini D, Macchioni P, Ruocco L, Paggiaro PL. Leukocyte counts in hypertonic saline-induced sputum in subjects with occupational asthma 550-7 Di Perna F see Cazzola M Dickinson J, Hutton S, Atkin A. Implementing the British Thoracic Society’s guidelines: the effect of a nurse-run asthma clinic on prescribed treatment in an English general practice 264-7 Dimopoulou I, Daganou M, Tsinstzas OK, Tzelepis GE. Effects of severity of long-standing congestive heart failure on pulmonary function 1321-5 Dluhy RG. Effect of inhaled beclomethasone dipropionate and budesonide on adrenal function, skin changes and cataract formation (S.B.) 15-23 Doboszynska A see Domagala-Kulawik J Doherty MJ, Campbell AP, Cowan ME, Greenstone MA. Bilateral endobronchial metastases due to a chondroblastic osteosarcoma 786-8 (CR) Kishore Kumar S, Nicholson AA, McGivern DV. Cardiac sarcoidosis: the value of MRI in diagnosis and assessmentof response to treatment 69779 (CR) Domagala-Kulawik J, Hoser G, Doboszynska A, Kawiak J, Droszcz W. Interstitial lung disease in systemic sclerosis:comparison of BALF lymphocyte phenotype and DLCO impairment 12955301 Domingo C see Comet R Donnell D see Thompson PJ Donohoe P see Kiely JL Dossing M see Wilcke JTR Douglas JG see McLean AN Douglas NJ see Mackay TW Douze JM see Kampelmacher MJ Dowson LJ, Mushtaq M, Watts T, Shurvinton J, Gooch R, Hayton R, Jones JM, Perks WH. A re-audit of pulmonary function laboratories in the West Midlands 1155-62 Doyon F see Maury E Drent M see Staal-van den Brekel AJ; Wirnsberger RM Droszcz W see Domagala-Kulawik J du Bois RM see Nageh, TT Dubinett SM see Meissner H-H Duce Gracia F see Vervloet D Duncan-Skingle F see Congleton J Dury M see Liistro G Eames C see Al-Ali MK Ebden P see Evans EN Edenborough FP see Hill AT

Edwards J see Roberts CM Eide GE see Svanes C Eklund A see Lensmar C Ekstriim T, Ringdal N, Sobradillo V, Runnerstrom E, Soliman S. Low-dose formoterol Turbuhaler@ (Oxis@) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.) 1040-5 see also Vervloet D Elmberger G see Lensmar C Emad A, Rezaian Gr. Closed percutaneous pleural brushing: a new method for diagnosis of malignant pleural effusions 659-63 Rezaian GR. Diagnostic value of closed percutaneous pleural biopsy vs pleuroscopy in suspected malignant pleural effusion or tuberculous plerisy in a region with a high incidence of tuberculosis: a comparative age-dependent study 488-92 Rezaian GR. Single pleural nodule in the minor fissure: an unusual manifestation of tuberculosis 7834 (CR) Emmanuel FXS see Dev D Empey DW see Taylor RFH Engh G see Carlsen K-H Enright PL see McDonnell WF Ernst P see Demissie K Escarrabill J, Estops R, Farrero E, Monasterio C, Manresa F. .Long-term mechanical ventilation in amyotrophic lateral sclerosis43841 Escudero C see Miravitlles M Espaiia PP see Miravitlles M Estops R see Escarrabill J Evald T see Clementsen P Evans EN, Ganeshalingham K, Ebden P. Changes in oxygen saturation and transcutaneous carbon dioxide and oxygen levels in patients undergoing fibreoptic bronchoscopy 73942 Evans MJ see Devereux G Evans MR see Ansari S Ewig S see Schafer H Farrero E see Escarrabill J Faurschou P see Clementsen P; Hansen M Ferini-Strambi L see Sergi M Ferrari M see Cogo AL Ferrer0 0 see Martinez Odriozola P Filley E see Kon OM Fink G, Lebzelter J, Turner D, Klainman ‘E, Shlomo M, Katz I, Kramer M, Spitzer S. Pulmonary function threshold for distinguishing ventilatoryand nonventilatory-limited patients with airflow obstruction 1245-50 Fireman Z seeWeiner P Fitch PS, Smith MEF, Davies MG, Prentice AG. A caseof lymphatoid granulomatosis mimicking sarcoidosis 966-8 (CR) Fitting J-W see JanssensJ-P Fiz JAF, Abad J, Riera M, Izquierdo J, Morera J. CPAP treatment interruption in OSA patients 28831 Fiz JM see Monso E Fluge 0 see Svanes C Fokkens JK see Jansons H Franklin DH see McLean AN Franklin J see Roberts CM Friberg K see Bondesson E Frisinghelli A see Confalonieri M Frossard N see Kopferschmitt-Kluber MC

Frost GD, Penrose A, Hall J, MacKenzie DIC. Asthmarelated prescribing patterns with four different corticosteroid inhaler devices 1352-8 Fugagnoli A see Cogo AL Fujimori K, Arakawa M. Clinical factors that affect blood gasesin non-smoking women with chronic liver disease 57-62 Fujimura M, Yasui M, Shinagawa S, Nomura M, Matsuda T. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and druginduced eosinophilic pneumonia 74339 Fujita J, Negayama K, Ohara M, Hojo S, Obayashi Y, Miyawaki H, Yamaji Y: Takahara J. Pneumonia caused by Pseudomonas putida with a mucoid phenotype 693-5 (CR) see also Hojo S; Yamanouchi H Fujiwara H see Yasuda N Fuller R see Verberne AAPH Furness L see Ansari S Fuso L see Antonelli Incaizi R Gabrielli M see PesciA Galavotti V see Clini E Gandola L see Confalonieri M Ganeshalingham K see Evans EN Garcia Pais MJ see Perez de Llano LA Garcia Salgado MJ see Losa Garcia JE Gautier-Dechaud V see Hayot M Gaya H see Taylor RFH Gazquez I, Parcel JM; Vives M, Vicente de Vera MC, Rubio M, Rivas MC. Comparative analysis of Light’s criteria and other biochemical parameters for distinguishing transudates from exudates 762-5 Gazzaniga P see Confalonieri M Gemma A see Antonelli Incaizi R Geroulanos S see Michaelopoulos A Giannini D see Di Franc0 A Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy 609923 Gilthorpe MS, Lay-Yee R; Wilson RC, Walters S, Griffiths RK, Bedi R. Variations in hospitalization rates for asthma among Black and ethnic minority communities 642-8 Glass DM see Ussov WY Gleissberg G see Kon OM Glerant JC see Hellmuth D Godard P see Demoly P Goh DYT see Chew FT Gomez F see Rodriguez MC Gomez J, Mota S; Casan P, Sanchis J. Pulse oximetry in smokers 989 (L) Gon Y see Matsumoto K Gonzalez-Juanatey JR see ValdCs L Gooch R see Dowson LJ Goodchild MC see Millar-Jones L : Gooszen HC see Roelofs PM Gorgels WJMJ see Schayk CP van . Gostelow B see Williams T Gotoh K see Yasuda N Govan JRW see Dev D Goyai M see Kon OM Graham DR see Kearney SE Greco M see Sergi M Greenstone MA see Doherty MJ Grier D see Bragonier R

Griffiths RK see Gilthorpe MS Grode G see Clementsen P Grossman AB see Thompson PJ .“’ ’ Grunsven PM van see Schayk CP van Guidet B see Maury E Guido P see Resta 0 Gulsvik A see Svanes C Gutierrez V see Prieto L Guzman J see Striz I Gyi KM see Yung B Hader S see Matthys D Hall IP see Johnson PH Hall J see Frost GD Hallas TE. Pitfalls in evaluating mite exposure from housedust samples 1099-101 Hallett C see Barnes NC Hamid S, Corden ZM, Ryan DP, Burnett I, Cochrane GM. Evaluation of an electronic hand-held spirometer in patients with asthma 1177-80 Kumaradevan J, Cochrane GM. Single centre open study to compare patient recording of PRN salbutamol use on a daily diary card with actual use as recorded by the MD1 compliance monitor 1188-90 Hancox M. Cattle TB crisis?Human implications 990-l (L) Hanley ML see Roberts CM Hansen M, Faurschou P, Clementsen P. Medical thoracoscopy, results and complications in 146 patients: a retrospective study 228-32 see also Clementsen P Haponik E see Omidvari K Hara H see Abe M Harbeck RJ see Watson BL Hardy CC see Simpson JCG Harirraj R see Charles TJ Harris TAJ see Barnes NC Harrison BDW see Partridge MR . Harrison LI see Seale JP Harrison TW, Tattersfield AE. Effec”t of single doses of inhaled lignocaine on FEV, and bronchial reactivity in asthma 1359963 Hasani A, Pavia D, Rotondetto S, Clarke SW, Spiteri MA, Agnew JE. Effect .of oral antibiotics on lung mucociliary clearance during exacerbation of chronic obstructive pulmonary disease 442-7 1’) Hasegawa S see Ishikawa H; Morishima Y ,i Hashimoto S see Abe M; Matsumoto K Hasper E see Schafer H Hayot M, Perrigault PF, Gamier-Dechaud V: Capdevila X: Milic-Emili J, Prefaut Ch, Ramonatxo M. Tensiontime index of inspiratory muscles in COPD patients: role of airway obstruction 828-35 .)‘JC Y”L Hayton R see Dowson LJ Heald SH see Simpson AJ Heck CL van see Wirnsberger RM ‘-; Hedman J; Poussa T, Nieminen MM. A rapid dosimetrii: methacholine challenge in asthma diagnostics: a clinical study of 230 patients with dyspnoea, wheezing or a cough of unknown cause 32,39 ,-, see also Seppala O-P Hellmuth D, Glerant JC, Sevestre H, Remond A, Jounieaux V. Pulmonary adenomatoid malformation presenting as unilobar cysts in adult 13647 (CR) 1. I., Hendrick DJ see Reid DW ii.

Henry M, Landers R, Kealy WF, Bredin, CP. Solitary columnar bronchial :papilloma: a rare endoscopic finding 878-9 (CR) \I Herrala J see Sepplla O-P Herwaarden CLA van see Palen J van der; Schayk CP van Heuman K see Montnemery P Hibon S see Carr DH Hildreth AJ see Parameswaran K Hill AT, Edenborough FP, Cayton RM, Stableforth DE. Long-term nasal intermittent positive pressure ventilation in patients with cystic fibrosis and hypercapnic respiratory failure (1991-1996) 523-6 Hopkinson RB, Stableforth DE. Ventilation in a Birmingham intensive care unit 1993-1995: outcome for patients with chronic obstructive pulmonary disease 156-61 Stewart PM, Hughes EA, McLeod DT. Cushing’s disease and tuberculosis 604-6 (CR) Hill FGH see Boldy DAR Hill LS, Slater AL. A comparison of the performance of two modern multidose dry powder asthma inhalers 10.5-10 Hillerdal G see Norman M Hines E see Nutman A Ho CL, Chang BC, Hsu GC, Wu CP. Pulmonary cryptococcoma with CD4 lymphocytopenia and meningitis in an HIV-negative patient 120-2 Hobbs J see Langton Hewer S Hodson ME see Congleton J; Yung B Hogan PG see Brown I Hoheisel G, Izbicki G, Roth M, Chan CHS, Leung JCK, Reichenberger F, Schauer J, Perruchoud AP. Compartmentalization of pro-inflammatory cytokines in tuberculous pleurisy 14-17 Hojo S, Fujita J, Yamadori I, Kamei T, Yoshinouchi T, Ohtusuki Y, Yamaji Y, Takahara J. Overexpression of p53 protein in interstitial lung diseases184-90 see also Fujita J; Yamanouchi H Hopkinson RB see Hill AT Horie T see Matsumoto K Horsfield N see Ormerdo LP Hoser G see Domagala-Kulawik J Hoshino GH, Nakamura Y, Sim JJ, Tomioko H. A comparative study of the effects of ketotifen, disodium cromoglycate and beclomethasone diprioponate on bronchial nucosa and asthma symptoms in patients with atopic asthma 942250 Howart H see Al-Ali MK Ijsu GC see Ho CL Huan PYM see Chee CBE Huang C-C, Lin M-C, Yang C-T, Lan R-S, Tsai Y-H, Tsao TCY. Oxygen, arterial blood gases and ventilation are unchanged during dialysis in patients receiving pressure support ventilation 534-40 Hubbard M see Picciotto A i” Hughes EA see Hill AT Hughes JMB see Ussov WY Hughes P see McGavin C Hulks G see Mackay TW Hutchison DCS. (1-antitrypsin deficiency in Europe: geographical distribution of Pi type S and Z 36777 Hutton S see Dickinson J Hyland ME see Singh SJ

Ide J see Roberts CM Ikeda A see Koyama H Ikeda H see Suzuki Y Ikeda Y, Yamashita H, Tamura T. Diffuse pulmonary ossification and recurrent spontaneous pneumothorax in a patient with bronchial asthma 887-9 (CR) Ind PW see Spanevello A Inuzuka M see Tanaka H Ip M see Tsang KWT Ishikawa H, Satoh H, Yamashita YT, Kamma H, Naito T, Ohtsuka M, Hasegawa S. Curved chest tube for drainage of malignant pleural effusion 633-7 Izbicki G see Hoheisel G Izquierdo J see Fiz JAF; Monso E Izquierdo R see Blanco-Perez J Izumi T see Koyama H Jackson M, Shneerson J. An evaluation of the use of concentrators for domiciliary oxygen supply for less than 8 h day- ’ 250-5 Jaffuel D see Demoly P Janes SM, Barker KF, Mak V, Bell D. Invasive pulmonary aspergillosis in an insulin-dependent diabetic 972-5 (CR) Jansons H, Fokkens JK, Tweel I van der, Kreukniet J. Re-breathing vs single breath 7X!O in patients with unequal ventilation and diffusion 18-24 Janssens J-P, Cicotti E, Fitting J-W, Rochat T. Noninvasive home ventilation in patients over 75 years of age: tolerance, compliance, and impact on quality of life 131l-20 Jansson C see Norrman E Jardi R see Miravitlles M Jarnvig I-L see Kristensen MS Jauregui I see Martinez Odriozola P Jeffery GM see McRae WM Jensen EJ, Pedersen B, Narvestadt E, Dahl R. Blood eosinophil and monocyte counts are related to smoking and lung function 63-69 Jensen G see Vestbo J Jensen JI see Benstrup KE Jeong SW see Uh S-T Jimenez Lopez A see Losa Garcia JE Johannisson A see Montnemery P Johansson S-A see Montnemery P Johnson PH, Wilkinson I, Sutherland AM, Johnston ISA, Hall IP. Improving communication between hospital and primary care increases follow-up rates for asthmatic patients following casualty attendance 289991 Johnston ISA see Johnson PH Jolobe OMP. Survival experience of the population needing hospital treatment for asthma or COPD at the age of 50-54 years 1256 (L) Jones JM see Dowson LJ Jones PW see Barley EA Jijnsson E see Larsson L-G; R&mark E Jorfeldt L see Norman M Jiirres RA see Kirsten DK Joseph L see Demissie K Jounieaux V see Hellmuth D Joyce C see Brown I Kaad P-H see Berg A von Kalayc 6 see Saraqlar Y

INDEX

Kalyoncu AF, Selquk ZT, Ciilit L. Epidemiological studies of adult bronchial asthma in Turkey 792 (L) Kamei T see Hojo S; Yamanouchi H Kaminski N see Kreiss Y Kamma H see Ishikawa H Kampelmacher MJ, Kestern RG van, Aslbach GPJ, Melissant CF, Wynne HJ, Douze JM: Lammers J-WJ. Characteristics and complaints of patients prescribed long-term oxygen therapy in the Nether!ands 70-75 Kapsner CO see Murata GH Karam G see Omidvari K Katz I see Fink G Kauppi P, Laitinen LA, Laitinen H, Kere J, Laitiinen T. Verification of self-reported asthma and allergy in subjects and their family members volunteering for gene mapping studies 1281-8 Kauppinen R, Sintonen H, Tukainen H. One-year economic evaluation of intensive vs conventional patient education and supervision for self-management of new asthmatic patients 300-7 Kawiak J see Domagala-Kulawik J Kealy WF see Henry M Keaney NP see Parameswaran K Kearney SE, Graham DR, Atherton ST. Acute severe asthma treated by mechanical ventilation: a comparison of the changing characteristics over a 17-year period 7 16-2 1 Keistinen T, Tuuponen T. Careful consideration needed with diagnoses of heart disease in COPD patients 1256-7 (L) Tuuponen T, Kivela S-L. Survival experience of the population needing hospital treatment for asthma or COPD at age 50-54 years 568-72 Kere J see Kauppi P Kerr KM see Devereux G Kestern RG van see Kampelmacher MJ Khalil MM, Rifaie OA. Electrocardiographic changes in obstructive sleep apnoea syndrome 25527 Ki SY see Uh S-T Kido M see Nikaido Y Kiely JL, Donohoe P, Bresnihan B, McNicholas WT. Pulmonary fibrosis in polymyositis with the Jo-l syndrome: an unusual mode of presentation 1167-9 (CR) Kim HT see Uh S-T Kim YH see Uh S-T Kirstein D see Schtirmann M Kirsten DK, Taube C: Lehnick B, Jorres RA, Magnussen H. Exercise training improves recovery in patients with COPD after an acute exacerbation 1191-8 Kishore Kumar S see Doherty MJ Kivell S-L see Keistinen T Kivity S see Nutman A Klainman E see Fink G Klein JJ see Palen J van der Klinkhamer PJ see Roelofs PM Knuistingh Neven A see Chisholm SL Knutsen SF see McDonnell WF Kobayashi M see Ohta T Koeter GH see Breukink SO Kok-Jensen A see Seersholm N Kon OM, Goyai M, Filley E, Gleissberg G, Cunningham D, Rook GAW, Shaw RJ. Mycobucterium vaccae: a study of safety and outcome measures 597-S (SR) Konson N see Weiner P Koorn M see Breukink SO

Kopferschmitt-Kluber MC, Frossard N, Rohde G, Pauli G. Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanateinduced asthma: a pilot study 1093-8 Kopp C see Vervloet D Korn SH, Thunnissen FBJM, Wesseling GJ, Arends J-W, Wouters EFM. Glucocorticoid receptor mRNA levels in bronchial epithelial cells of patients with COPD: influence of glucocorticoids 1102-9 Koyama H, Nishimura K, Ikeda A, Tsukino M, Izumi T. A comparison of different methods of spirometric measurement selection 4988504; Comparison of four types of portable peak flow meters (Mini-Wright, Assessm Pulmo-graph and Wright Pocket meters) 505-l 1 Krag Jacobsen G see Clementsen P Kramer M see Fink G Kreiss Y, Schwartz E, Kaminski N, Raanani P, Schiby 6, Zvas Z, Sidi Y. Unique pulmonary presentation of intravascular large cell lymphoma 1087-9 Kreukniet J see Jansons H Kreuzer H see Andreas S Kristensen MS; Milman N; Jarnvig I-L. Pulse oximetry at fibre-optic bronchoscopy in local anaesthesia: indications for postbronchoscopy oxygen supplementation? 432-7 Kumada H see Yasuda N Kumaradevan J see Hamid S Kunkel G see Matthys D la Rosa M see Berg A von Labinjoh C, Selby C. Dermatomyositis associated with small cell carcinoma of the lung: dramatic response to corticosteroid therapy 601-6 (CR) Lai Y-F see Liu S-F Laitiinen T see Kauppi P Laitinen H see Kauppi P Laitinen LA see Kauppi P; Lijfdahl C-G Lam W-K see Tsang KWT Lammers J-WJ see Kampelmacher MJ Lan R-S see Huang C-C Landers A see Yung B Landers R see Henry M Lane SJ. Leukotriene antagonism in asthma and rhinitis 7955809 Lange P see Vestbo J Langevitz P see Aharon A Langton Hewer S, Hobbs J: Reid F, Lenney W. Prednisolone in acute childhood asthma: clinical responses to three dosages 541-6 Larsen F see Norman M Larsson K see Wang Z; Zetterlund A Larsson L-G, Lundback B, Jiinsson E, Lindberg A, Sandstrom T. Are symptoms of obstructive sleep apnoea syndrome related to bronchitic symptoms or lung function impairment? Report from the Obstructive Lung Disease in Northern Sweden Study 283-8 Larsson PH see Zetterlund A Laserna B see Perez de Llano LA Laub M see Milman N Lay-Yee R see Gilthorpe MS Leach CL. Improved delivery of inhaled steroids to the large and small airways (S.A.) 3-8 Lebowitz MD see McDonnell WF Lebzelter J see Fink G

Lee BW see Chew FT Lee M see Skwarski K Lee P see Chee CBE Lee T-Y see Liu S-F Legge JS see Devereux G Lehnick B see Kirsten DK Leitch AG see Simpson AJ Lenney W see Langton Hewer S Lensmar C, Elmberger G, Skiild M, Eklund A. Smoking alters the phenotype of macrophages in induced sputum 415-20 Leung JCK see Hoheisel G Lewis SA, Britton JR. Consistent effects of high socioeconomic status and low birth order, and the modifying effect of maternal smoking on the risk of allergic disease during childhood 123744 Liipo K see Seppala O-P Liistro G, Rombaux P, Dury M, Pieters T, Aubert G, Rodenstein DO. Effects of Breathe Right@ on snoring: a polysomnographic study 106669 Lim G-I see Uh S-T Lim S, MacRae KD, Seed WA, Roberts CM. The value of FEV, in screening subjects with stable COPD for PaO, ~7.3 kPa in patients qualifying for long-term 0, therapy 1122-6 Lin A-S. see Liu S-F Lin M-C see Huang C-C Lin W-C see Perng R-P Lindberg A see Larsson L-G Lindholm L-H see Montnemery P Lindholm N see Norrman E Liu JM see Perng R-P Liu S-F, Lee T-Y, Wong S-L, Lai Y-F, Lin A-S. Transient cortical blindness: a complication of bronchial artery embolization 98336 Lium DJ see Murata GH Llopis R see Cremades MJ Liifdahl C-G, Postma DS, Laitinen LA, Ohlsson SV, Pauwels RA, Pride NB. The European Respiratory Society study on chronic obstrutive pulmonary disease (EUROSCOP): recruitment methods and strategies 467-72

see also Bondesson E; Montnemery P; Nana A Losa Garcia JE, Mateos Rodriguez F, Jimenez Lopez A, Garcia Salgado MJ, Martin de Cabo MR, Perez Losada J, Perez Arellano JL. Effect of cycolosporin A on inflammatory cytokine production by human alveolar macrophages 722-8 Lbtvall J see Palmqvist M Lijwhagen 0 see Palmqvist M Luburich P see Xaubet A LudeHa MD see Rodriguez MC Liideritz B see Schafer H Lundback B see Larsson L-G; Montnemery P; Norrman E; Ronmark E :7 Macchioni P see Di Franc0 A Mackay TW, Hulks G, Douglas NJ. Non-adrenergic, noncholinergic function in the human airway 461-6 MacKenzie DIC see Frost GD MacNee W see Skwarski K MacRae KD see Lim S Maesen FPV see Noord JA van Magnussen H see Kirsten DK Majori M see PesciA

Mak V see Janes SM Makayama T see Matsumoto K Malmberg P see Wang Z Mamun M see Alcock SM; Connolly CK Manninen A see Wang Z Manousos 0 see Tzanakis N Manresa F see Escarrabill J Manuel Valle J see Valdes L Maran R see Aharon A Maranetra N see Nana A Marchesini L see Baraldi E Marin A see Comet R Marin J see Prieto L Marques-Magallanes JA, Storer TW, Cooper CB. Treadmill exercise duration and dysponea recovery time in chronic obstructive pulmonary disease: effects of oxygen breathing and repeated testing 735-8 Marshall BG, Wilkinson RJ, Davidson RN. Pathogenesis of tropical pulmonary eosinophilia: parasitic alveolitis and parallels with asthma 1-3 Martin de Cabo MR see Losa Garcia JE Martinez MT see Miravitlles M Martinez Odriozola P, Ferrer0 0, Jauregui I, Miguel F. Alglucerase treatment of type 1 Gaucher disease with pulmonary involvement 1370-2 Martini T see Nutini S Maruyama M see Ohta T Mata I see Perez de Llano LA Mateos Rodriguez F see Losa Garcia JE Matera MG see Cazzola M Mathalone B see Yung B Matsuda R see Tomita H Matsuda T see Fujimura M Matsumoto K, Hashimoto S, Gon Y, Makayama T, Takizawa H, Horie T. N-Acetylcysteine inhibits IL-lainduced IL-8 secretion by bronchial epithelial cells 512-15 Matsumoto Y see Suzuki Y Matthys H, Nowak D, Hader S, Kunkel G. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 ,uglday delivered as an extrafine aerosol in adults with moderate asthma (S.A.) 17-22 Maury E, Doyon F, Guidet B, Moty A, Offenstadt G. Drainage of spontaneous pneumothorax using an intravenous catheter. Immediate and long-term results 961-2 (TN) Mavrofridis E see Patakas D McConnell SA see Waller DA McDonnell WF, Enright PL, Abbey DE, Knutsen SF, Peters JA, Burchette RJ, Lebowitz MD. Spirometric reference equations for older adults 91421 McGavin C, Hughes P. Finger clubbing in malignant mesothelioma and benign asbestos pleural disease 691-2 (SR) McGibbon K see Peckham DG McGivern DV see Doherty MJ McKenzie SA see Picciotto A McLean AN, Semple Pd’A, Franklin DH, Petrie G, Millar EA, Douglas JG. The Scottish multi-centre prospective study of bronchoscopy for bronchial carcinoma and suggested audit standards 1110-l 5 McLeod DT see Hill AT McNicholas WT see Kiely JL McRae WM, Wong CS, Jeffery GM. Endobronchial nonHodgkin’s lymphoma 975-7 (CR)

Meissner H-H, Robinson L, Dubinett SM, Santiago SM. Pulmonary edema as a result of chronic upper airway obstruction 11746 (CR) Melillo G see DahlCn B Melissant CF see Kampelmacher MJ Memendez R see Cremades MJ Mendel S see Nutman A Metlay JP, Atlas SJ, Borowsky LH, Singer DE. Time course of symptom resolution in patients with community-acquired pneumonia 113742 Michaelopoulos A, Anthi A, Rellos K, Geroulanos S. Effects of positive end-expiratory pressure (PEEP) in cardiac surgery patients 858-62 Nikolaides A, Antzaka C, Deliyanni M, Smirli A, Geroulanos S, Papadimitriou L. Change in anaesthesia practice and postoperative sedation shortens ICU and hospital length of stay following coronary artery bypass surgery 1066-70 Michel F-B see Demoly P Micheletto C see Cogo AL Migliori GB see Spanevello A Miguel F see Martinez Odriozola P Milic-Emili J see Hayot M Millar EA see McLean AN Millar-Jones L, Ryley HC, Pauli A, Goodchild MC. Transmission and prevalence of Buskholderia cepacia in Welsh cystic fibrosis patients 178-83 Milman N, Laub M, Munch EP, Angelo HR. Serum concentrations of lignocaine and its metabolite monoethylglycinexylidide during fibreoptic bronchoscopy in local anaesthesia 4043 Msller Pedersen F. Idiopathic pulmonary haemosiderosis. Epidemiology, pathogenic aspects and diagnosis 902-7 see also Kristensen MS Minatoguchi S see Yasuda N Miravitlles M, Vidal R: Barros-Tizhn JC, Bustamante A, Espafia PP, Casas F, Martinez MT, Escudero C: Jardi R. Usefulness of a national registry of alpha-lantitrypsin deficiency. The Spanish experience 118 l-7 Miyake S see Shishido H Miyawaki H see Fujita J Molema J see Schayk CP van Merller Pedersen F see Milman N Monasterio C see Escarrabill J Manse E, Fiz JM, Izquierdo J, Alonso J, Co11 R, Rose11 A, Morera J. Quality of life in severe chronic obstructive pulmonary disease: correlation with lung and muscle function 221-7 Montnemery P, Adelroth E, Heuman K, Johannisson A, Johansson S-A; Lindholm L-H, Lundback B, Lijfdahl C-G. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden 133745 Moon SH see Uh S-T Moorat A see Berg A von Morales C see Prieto L Moreda M see Perez de Llano LA Morera J see Fiz JAF; Monso E Morgan MDL see Revill SM; Singh SJ Mori T see Tomita H Morishima Y, Satoh H, Ohtsuka M, Yazawa T: Yamashita Y, Hasegawa S. Primary mediastinal nonseminomatous germ cell tumour in an adult female 882-4 (CR) Mark M see Carlsen K-H Morrison D see Skwarski K

Mota S SEE Gomez J Motomiya M see Shiraishi K Moty A see Maury E Mouzas J see Tzanakis N Mower WR; Sachs C, Nicklin EL, Safa P, Baraff LJ. Pulse oximetry in smokers 989-90 (L) Miihlen F von zur see Andreas S Miiller-Quernheim J. Sarcoidosis: clinical manifestations, staging and therapy (part II) 140-9 see also Schiirmann M; Zissel G Miiller-Suur C see Zetterlund A Munch E see Bisgaard H Munch EP see Milman N Muiioz X see Orriols R Murata GH, Kapsner CO, Lium DJ, Busby HK. Time course of respiratory decompensation in chronic obstructive pulmonary disease: a prospective doubleblind study of peak flow changes prior to emergency department visits 93641 Mushtaq M see Dowson LJ Myers MJ see Ussov WY Mygind N; Dahl R, Nielsen LP. Effect of nasal inflammation and of intranasal anti-inflammatory treatment on bronchial asthma 547-9 Nagata N see Nikaido Y Nageh TT, du Bois RM. Non-invasive ventilation in hypercapnic respiratory failure secondary to sclerodermic chest wall restriction 1170-2 (CR) Naik SK see Carter R Naish J see Picciotto A i Naito T see Ishikawa H Nakamura Y see Hoshino GH Nana A, Youngchalyyud P, Maranetra N: Boe J, Lofdahl C-G, Selroos 0, St&l E. ,&agonists administered by a dry powder inhaler can be used in acute asthma 167-72 Narvestadt E see Jensen EJ Negayama K see Fujita J Nelson S see Omidvari K Neri M see Spanevello A Nicholson AA see Doherty MJ Nicklin EL see Mower WR Nielsen LP see Mygind N Nieminen MM see Hedman J; Seppala O-P Niime T see Tomita H Nikaido Y, Nagata N, Yamamoto 7, Yoshii C, Ohmohi H, Kido M. A case of allergic bronchopulmonary aspergillosis successfully treated with itraconazole 118-19 (CR) Nikander K see Bisgaard H Nikolaides A see Michalopoulos A Nishigaki K see Yasuda N Nishimura K see Koyama H Noliet AS, Vansteenkiste JF, Demedts MG. Broncholithiasis: rare but still present 96335 (CR) Nomura-M see Fujimura M; Yasuda N Noord JA van, Smeets JJ, Maesen FPV. A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction 1346-5 1 Norman M, Hillerdal G, Orre L, Jorfeldt L, Larsen F, Cederlund K, Zetterberg G; Unge G. Improved lung function and quality of life following increased elastic recoil after lung volume reduction surgery in emphysema 653-8

Norrman E, Plaschke P, Bjornsson- E, Rosenhall L, Lundback B, Jansson C, Lindholm N, Boman G. Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden 480-7 Nowak D see Gillissen A; Matthys D Nukiwa T see Shiraishi K Numata M see Suzuki Y Nutini S, Martini T, Righi R. Long-term treatment of asthmatic patients with salmeterol vs slow-release theophylline 683-90 Nutman A, Solomon Y, Mendel S, Nutman J, Hines E, Topilsky M, Kivity S. The use of a neural network for studying the relationship betwen air pollution and asthma-related emergency room visits 11999202 Nutman J see Nutman A Nybo Jensen B see Wilcke JTR Nyholm J-E see SeppLll O-P O’Connor BJ see Davies RJ O’Neill A see Roberts CM O’Reilly JF, Weir DC, Banham S, Basran GS, Boyd G, Pate1 KR. Is high-dose flutacasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics? 11l-17 Obayashi Y see Fujita J Offenstadt G see Maury E Ogisu N see Tomita H Ohara M see Fujita J Ohchi T, Tanaka H, Shibuya Y, Shibusa T, Inuzuka M, Satoh M, Abe S. Thymic carcinoid with mutinous stroma: a case report 880-2 C(R) Ohlsson SV see Lijfdahl C-G Ohmohi H see Nikaido Y Ohno A see Yasuda N Ohta T, Yamashita N, Maruyama M, Sugiyama E, Kobayashi M. Cigarette smoking decreases interleukin-8 secretion by human alveolar macro!,1 phages 922-7 Ohtsuka M see Ishikawa H; Morishima Y Ohtsuki Y see Yamanouchi H Ohtusuki Y see Hojo S Okubo T see Suzuki Y Omenaas E see Svanes C Omidvari K, de Boisblanc BP, Karam G, Nelson S, Haponik E, Summer W. Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis 1032-9 Ong KC, Clerk AA. Comparison of the sever& of sleepdisordered breathing in Asian and Caucasian patients seen at a sleep disorders center 843-8 Ooi BC see Chew FT i, Ormerod LP, Horsfield N, Alani FSS. How frequently do endobronchial secondaries occur in an unselected series?599-600 (SR) Orre L see Norman M Orriols R, Muiioz X, Alvarez A, Sampol G. Chest CT scanning: utility in lung endometriosis 876-7 (CR) Osman L. Health habits and illness behaviour: social factors in patient self-management 150-5 Overdiep SH see Pomp J Paggiaro PL see Di Franc0 A Palen J van der, Klein JJ, Zielhuis GA, Herwaarden CLA van. The role of self-treatment guidelines in selfmanagement education for adult asthmatics 668-75

Palmberg L see Zetterlund A Palmqvist M, Pettersson K, Sjiistrand M, Andersson B, Lawhagen 0, Liitvall J. Mild experimental exacerbation of asthma induced by individualised low-dose repeated allergen exposure. A double-blind evaluation 1223-30 Panagou P see Tzanakis N Pang SC. Chest radiography and tuberculosis case-finding in Western Australia 1988202 Pannekoek BJM see Pomp J Pantin C see Peckham DG Papadimitriou L see Michalopoulos A Parameswaran K, Hildreth AJ, Chadha D, Keaney NP, Taylor IK, Bansai SK. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey 573-7 Park CS see Uh S-T Partridge MR, Harrison BDW, Bellamy D, Silverman M. The British Asthma Guidelines - their production, dissemination and implementation 1046652 Parwer S see Abel AT Pastor A see Cremades MJ Patakas D, Andreadis D, Mavrofridis E, Argyropoulou P. Comparison of the effects of salmeterol and ipratropium bromide on exerciseperformance and breathlessness in patients with stable chronic obstructive disease 1116-21 Pate1 KR see O’Reilly JF Patsourakis G see Bouros D Pauli A see Millar-Jones L Pauli G see Kopferschmitt-Kluber MC Pauweis R see Ringdal M, Pauwels RA see Lijfdahl C-G Pavia D see Hasani A Pavord I see Dawson S Peake MD see Biernacki W Peckham DG, McGibbon K, Tonkinson J, Plimbley G, Pantin C. Improvement in patient compliance with long-term oxygen therapy following formal assessment with training 1203-6 Pedersen B see Jensen EJ Pela R see Vervloet D Penela P see Valdes L Penrose A see Frost GD Perez Arellano JL see Losa Garcia JE Perez de Llano LA, Soilan JL, Garcia Pais MJ, Mata I, Moreda M, Laserna B. Idiopathic bronchiolitis obliterans with organizing pneumonia presenting with adult respiratory distress syndrome 884-6 (CR) Perez Losada J see Losa Garcia JE Perks WH see Dowson LJ Perng R-P. Chen Y-M, Wu M-F, Chou K-C, Lin W-C, Liu JM, Whang-Peng J. Phase II trial of intrapleural paclitaxel injection for non-small lung cancer patients with malignant pleural effusions 473-9 Perrigault PF see Hayot M Perruchoud AP see Hoheisel G Pesci A, Majori M, Cuomo A, Borciani N, Bertacco S, Cacciani G, Gabrielli M. Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary disease 863-70 Peters AM see Ussov WY Peters JA see McDonnell WF Petri H see Chisholm SL Petrie G see McLean AN

INDEX

Pettersson K see Palmqvist M Pham B see Aaron SD Picca V see Resta 0 Picciotto A, Hubbard M, Sturdy P, Naish J, McKenzie SA. Prescribing for persistent cough in children 63841 Pierce JD; Clancy RL, Trank JW; Burris J. Diaphragm shortening and intrathoracic pressure during hypercapnia in rats 4-8 Pieters T see Liistro G Pietinalho A see Seppala O-P Pifiiro-Amigo L see Blanco-Perez J Pison C see Devouassoux G Pistelli R see Antonelli Incaizi R Plaschke P see Norrman E Platts-Mills T see Ronmark E Plimbley G see Peckham DG Poh SC see Chee CBE Pokorna H see Striiz I Pomp J, Pannekoek BJM, Overdiep SH. Pleomorphic adenoma and severe tracheal obstruction 889-91 (CR) Parcel JM see Gazquez I Porta R see Clini E Postma DS see Lofdahl C-G Postmus PE see Smit HJM Potter JF see Dawson S Poussa T see Hedman J Prefaut Ch see Hayot M Prentice AG see Fitch PS Prescott E see Vestbo J Prescott RJ see Alcock SM; Connolly CK Price DB, Appleby JL. Fluticasone propionate: an audit of outcomes and cost-effectivenessin primary care 351-3 Cargill K, Wolfe S, Darby H. Salmeterol xinafoate: an analysis of outcomes and cost-effectiveness using a primary care database 1302-4 (SR) Pride NB see Liifdahl C-G Prieto L, Gutierrez V, Morales C, Marin J. Differences in sensitivity, maximal response and position of the concentration-response curve to methacholine between asthmatics, patients with allergic rhinits and healthy subjects 88-94 Psathakis K see Bouros D Quebe-Fehling E see Thomson NC; Vervloet D Quirk FH see Barley EA Raanani P see Kreiss Y Rajesh PB see Waller DA Ramirez J see Soler N Ramonatxo M see Hayot M Rees PJ see Corden Z Reichenberger F see Hoheisel G Reid DW, Bromly CL, Stenton SC, Hendrick DJ, Bourke SJ. A double-blind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma 1010-11 Reid F see Langton Hewer S Reintoft I see Benstrup KE Rellos K see Michaelopoulos A Remond A see Hellmuth D Resta 0, Guido P, Picca V, Sabato R, Rizzi Ma Scarpelli F, Sergi M. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two-centre study 820-7

Revill SM, Morgan MDL. The cardiorespiratory response to submaximal exercisein subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterol 105338 Rezaian GR see Emad A Ribera G see Comet R Riera M see Fiz JAF Rifaie OA see Khalil MM Righi R see Nutini S Ringdal M, Derom E, Wahlin-Boll E, Pauweis R. Onset and duration of action of single doses of formoterol inhaled via Turbuhalera 1017-2 1 Ringdal N see Ekstriim T Rivas MC see Gazquez I Rizzi M see Resta 0; Sergi M Roberts CM, Franklin J, O’Neill A, Roberts RP, Ide J, Hanley ML, Edwards J. Screening patients in general practice with COPD for long-term domiciliary oxygen requirement using pulse oximetry 1265-8 see also Lim S Roberts RP see Roberts CM Robinson BWS see Venaille TJ Robinson L I see Meissner H-H Rota J, Burgos F: Barbera JA, Sunyer J: Rodriguez-Roisin R, Castellsague J, Sanchis J, Antbo JM, Casan P, Clausen JL. Prediction equations for plethysmographic lung volumes 454-60 see also Castellsague J; Xaubet A Rota-Serrano R see Blanco-Perez J Rochat T see JanssensJ-P Rodenstein DO see Liistro G Rodriguez MC, Capurro M, Gomez F, Ludeca MD. Migratory pulmonary infiltrates 10814 Rodriguez-Roisin R see Rota J; Soler N; Xaubet A Roelofs PM, Klinkhamer PJ, Gooszen HC. Hypersensitivity pneumonitis probably caused by cyclosporine. A case report 1368-70 (CR) Rohde G see Kopferschmitt-Kluber MC Rokkas T see Bouros D Rombaux P see Liistro G Ronmark E: Lundback B, Jiinsson E, Platts-Mills T. Asthma, type-l allergy and related conditions in 7- and g-year-old children in Northern Sweden: prevalence rates and risk factor pattern 316-24 Rook GAW see Kon OM Roomi J see Yohannes AM Rose11A see Monso E Rosenhall L seeNorrman E Roth M see Hoheisel G Rotondetto S see Hasani A Roy TM see Byrd RP Rozman C see Soler N Rubens M see Carr DH Rubio M see Gazquez I Runnerstrom E see Ekstrom T Ruocco L see Di Franc0 A Ryan DP see Hamid S Ryan G see Venaille TJ Ryley HC see Millar-Jones L Sabato R see Resta 0 Sachs C see Mower WR Safa P see Mower WR Sahla H see Demoly P Samiou M see Tzanakis N

INDEX

Sampol G see Orriols R Sanakaran R see Dev D Sanchis J see Gomez J; Rota J Sandstrom T see Larsson L-G Sano H see Yasuda N Sans J see Comet R Santiago SM see Meissner H-H Sanyai SC see Abel AT Saraclar Y. Epidemiological studies of adult bronchial asthma in Turkey.,792-3 (L) Sekerel BE, Kalayc 0, Cetinkaya F, Adalioglu G, Tuncer A, Tezcan S. Prevalence of asthma symptoms in school children in Ankara, Turkey 203-7 Sasaki H see Shiraishi K Sato S see Tomita H Satoh H see Ishikawa H; Morishima Y Satoh M see Tanaka H Satta A see Spanevello A Sawa T see Yasuda N Scarduelli C see Clini E Scarpelli F see Resta 0 Schaaning J, Strom K, Boe J. Do patients using long-term liquid oxygen differ from those on traditional treatment with oxygen concentrators and/or compressed gas cylinders? A comparison of two national registers 84-87 Schafer H, Ewig S, Hasper E, Ltideritz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure 208-l 5 Schans CP van der see Breukink SO Schauer J see Hoheisel G Schayk CP van, Dekhuijzen PNR, Gorgels WJMJ, Grunsven PM van, Molema J, Herwaarden CLA van, Wee1 C van. Are anti-oxidant and anti-inflammatory treatments effective in different subgroups of COPD? A hypothesis 1259-64 Schiby G see Kreiss Y Schlaak M see Schiirmann M Schnohr P see Vestbo J Schriider E see Carlsen K-H Schiirmann M, Bein G, Kirstein D, Schlaak M, MtillerQuernheim J, Schwinger E. HLA-DQBl and HLADPBl genotypes in familial sarcoidosis 649-52 Schwartz E see Kreiss Y Schwinger E see Schiirmann M Seale JP, Harrison LI. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics (S.A.) 9-16 Seed WA see Lim S Seersholm N, Kok-Jensen A. Intermediate aiantitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema? 24 l-5 Sekerel BE see Saraclar Y Selby C see Labinjoh C Selcuk ZT see Kalyoncu AF Selroos 0 see Nana A Semple Pd’A see McLean AN Seppala O-P, Herrala J, Hedman J, Alanko K, Liipo K, Terho E, Pietinalho A, Nyholm J-E, Nieminen”MM. The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer 578-83

Sergi M, Rizzi M, Greco M, Andreoli A, Bamberga M, Castronovo C, Ferini-Strambi L. Validity of diurnal sleep recording performed by an ambulatory device in the diagnosis of obstructive sleep apnoea 216-20 see also Resta 0 SevestreH see Hellmuth D Sharara A see Spanevello A Shaw RJ see Kon OM Sheung SW see Wong CF Shibusa T see Tanaka H Shibuya Y see Tanaka H Shimizu S see Tomita H Shinagawa S see Fujimura M Shiraishi K, Sasaki H, Yaekashiwa M, Motomiya M, Nukiwa T. Total respiratory system compliance after thoracoplasty 810-14 Shishido H, Deguchi K, Miyake S, Akagawa S, Yoshizawa Y. Mulitple drug-resistant Nocardia asteroides isolated from a patient with pulmonary nocardiosis 873-5 C(R) Shlomo M see Fink G Shneerson J see Jackson M Short PE see Boldy DAR Shtrasburg S, Livneh A see Aharon A Shurvinton J see Dowson LJ Siafakis N see Tzanakis N Sidi Y see Kreiss Y Silverman M see Partridge MR Silvert BD see Vervloet D Sim JJ see Hoshino GH Simpson AJ, Tweeddale PM, Crompton GK. Starting home nebulizer therapy: patients’ expectations and subsequent outcome at 2 months 1000-2 Watt B, Heald SH, Sudlow MF, Leitch AC. The management of pulmonary tuberculosis in adults notified in Scotland 1289-94 Simpson JCG, Callaway MP, Taylor PM, Hardy CC. Recurrent venous obstruction caused by sarcoidosis 785-6 (CR) Singer DE see Metlay JP Singh SJ, Smith DL, Hyland ME, Morgan MDL. A short outpatient pulmonary rehabilitation programme: immediate and longer term effects on exerciseperformance and quality of life 1146-54 Sintonen H see Kauppinen R Sjijstrand M see Palmqvist M Skiild M see Lensmar C Skwarski K, Morrison D, Barratt A, Lee M, MacNee W. Effects of hypoxia on renal hormonal balance in normal subjects and in patients with COPD 13313-6 Slater AL see Hill LS Smeets JJ see Noord JA van Smirli A see Michalopoulos A Smit HJM, Chatrou M, Postmus PE. The impact of spontaneous pneumothorax, and its treatment, on the smoking behaviour of young adult smokers 1132-6 Smith DL see Singh SJ Smith MEF see Fitch PS Sobradillo V see Ekstrdm T Soilen JL see Perez de Llano LA ” Soler N, Babera IA, Ramirez J, Bat116 M, Rozman C, Rodriguez-Roisin R. Pulmonary Langerhans’ cell histiocytosis following autologous haemopoietic progenitor cell transplantatibn 1253-5 (CR) Soliman S see Bondesson E; Ekstrijm T Solomon Y see Nutman A ’

Spanevello A, Migliori GB, Satta A, Sharara A; Ballardini L, Ind PW, Neri M. Bronchoalveolar lavage causes decrease in PaO, increase in (A-a) gradient value and bronchoconstriction in asthmatics 191-7 Spiteri MA see Hasani A Spitzer S see Fink G Spyt T see Williams T Staal-van den Brekel AJ, Dentener MA, Drent M, Velde GPM ten, Bum-man WA, Wouters EFM. The enhanced inflammatory response in non-small cell lung carcinoma is not reflected in the alveolar compartment 76-83 Stableforth DE see Hill AT St%1E see Nana A Stampone P see Davies RJ Steele R see Brown I Stenton SC see Reid DW Sternberg A see Weiner P Stevens J see Andreas S Stevenson RD see Carter R Stewart PM see Hill AT Storer TW see Marques-Magallanes JA Strijbos JH see Breukink SO Striz I, Pokorna H, Zheng L, Guzman J, Costabel U. Different expression of integrins by mononuclear phagocytes in peripheral blood and BALF 1326-30 Strom K. Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: a risk factor for hospitalization and mortality in women. see also Schaaning J Sturani C see Clini E Sturdy P see Picciotto A Such JJ see Comet R Sudlow MF see Simpson AJ Sugiyama E see Ohta T Summer W see Omidvari K Sunyer J see Castellsague J; Rota J Sutherland AM see Johnson PH Suzuki J see Suzuki Y Suzuki S see Suzuki Y Suzuki Y, Suzuki S, Numata M, Matsumoto Y, Suzuki J; Ikeda H, Okubo T. Acute respiratory failure due to miliary tuberculosis in a patient with idiopathic CD4’ T-lymphocytopaenia 977-9 (CR) Svanes C, Omenaas E, Eide GE, Fluge 0, Gulsvik A. Hospitalization for lung diseasein early childhood and asthma symptoms in young adulthood 1003-9 Takahara J see Fujita J; Hojo S; Yamanouchi H Takizawa H see Matsumoto K Tamura T see Ikeda Y Tanaka H see Tanaka H Tattersfield Ae see Harrison TW Taube C see Kirsten DK ‘L Taylor IK see Parameswaran K Taylor PM see Simpson JCG Taylor RFH, Gaya H, Empey DW. A new approach to the treatment of Xantlzoinonas maltoplzila respiratory infection in a patient with cystic fibrosis 3634 (CR) Terho E see Seppala O-P Tezcan S see Saraqlar Y Thomas S see Ansari S

Thompson PJ, Davies RJ; Young WF: Grossman AB, Donnell D. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol (S.A.) 33-9 Thomson NC, Angus R; Quebe-Fehling E, Brambilla R. Efficacy and tolerability of formoterol in elderly patients with reversible obstructive airways disease 562-7 Thunnissen FBJM see Korn SH Tomioko H see Hoshino GH Tomita H: Sato S, Matsuda R, Ogisu N, Mori T, Niime T, Shimizu S. Genetic polymorphism of the ACE in asthmatic patients 1305-10 Tonkinson J see Peckham DG Tony F see Devouassoux G Topilsky M see Nutman A Torrice MP see Antonelli Incaizi R Trank JW see Pierce JD Tsai Y-H see Huang C-C Tsang KWT, Lam W-K, ip M. Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy 788-90 (CR) Tsao TCY see Huang C-C Tsinstzas OK see Dimopoulou I Tsukino M see Koyama H Tukainen H see Kauppinen R Tuncer A see Saraqlar Y Turner D see Fink G Tuuponen T see Keistinen T Tweeddale PM see Simpson AJ Tweel I van der see Jansons H Tzanakis N, Bouros D, Samiou M; Panagou P, Mouzas J, Manousos 0, Siafakis N. Lung function in patients with inflammatory bowel disease 5 16622 see also Bouros D Tzelepis GE see Dimopoulou I Ueda N see Yamanouchi H Uh S-T, Ki SY, Lim G-I, Moon SH, Jeong SW, Kim HT, Kim YH, Park CS. The T cell receptor subsets of lymphocytes in bronchoalveolar lavage in patients with active pulmonary tuberculosis 408-14 Unge G see Norman M Ussov WY, Peters AM, Myers MJ, Glass DM, IIughes JMB. Bimodal granulocyte transit time through the human lung demonstrated by deconvolution analysis 1163-6 (SC) Vagaggini B see Di Franc0 A ValdCs L, Gonzalez-Juanatey JR, Alvarez D, Antunez J; Manuel Valle J, Penela P, Alvarez-Sala R. Diagnosis of pulmonary veno-occlusive disease: new criteria for biopsy 979-83 (CR) Van de Heyning P see Boudewyns A Vansteenkiste JF see Nollet AS Velde GPM ten see Staal-van den Brekel AJ Venaille TJ, Ryan G, Robinson BWS. Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum 23340 Verberne AAPH, Fuller R. An overview of nine clinical trials of salmeterol in an asthmatic population 777-82 Vervloet D, Ekstriim T; Pela R, Duce Gracia F, Kopp C, Silvert BD, Quebe-Fehling E, Della Cioppa 6,

INDEX

Di Benedetto G. A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease 83642 Vestbo J, Prescott E, Lange P, Schnohr P, Jensen G. Vital prognosis after hospitalization for COPD: a study of a random population sample 772-6 Vicente de Vera MC see Gazquez I Vidal R see Miravitlles M Vinciguerra A see Cazzola M Vitacca M see Clini E Vives M see Gazquez I Wahlin-Boll E see Ringdal M Walamies MA. Thoracic gas compression profile during forced expiration in healthy and asthmatic schoolchildren 173-7 Wallace E see Dev D Waller DA, McConnell SA, Rajesh PB. Delayed referral reduces the success of video-assisted thoracoscopic surgery for spontaneous pneumothorax 246-9 Walters S see Gilthorpe MS Wang YT see Chee CBE Wang Z, Manninen A, Malmberg P, Larsson K. Inhalation of swine-house dust increases the concentration of interleukin-1 beta (IL-l/$ and interleukin-1 receptor antagonist (IL-lra) in peripheral blood 1022-7 Watanabe M see Yasuda N -* Waters K see Yohannes AM Wathen CG see Dev D Watson BL, Cormier RA, Harbeck RJ. Effect of pH on the stability of methacholine chloride in solution 588-92 Watt B see Simpson AJ Watts T see Dowson LJ Webb DR. Efficacy of inhaled beclomethasone dipropionate and budesonide in the treatment of asthma (S.B.) 7-14 Wee1 C van see Schayk CP van Weiner P, Konson N, Sternberg A, Zamir D, Fireman Z. Is gastro-oesophageal reflux a factor in exercise-induced asthma? 1071-5 Weir DC see O’Reilly JF Wesseling GJ see Korn SW Whang-Peng J see Perng R-P Wheatley DJ see Carter R Wilcke JTR, Askgaard DS, Nybo Jensen B, Dossing M. Radiographic spectrum of adult pulmonary tuberculosis in a developed country 493-7 Wilkinson I see Johnson PH Wilkinson RJ see Marshall BG Williams T, Gostelow B, Woods D, Spyt T. Apical pleural mass developing following talc pleurodesis 358-64 CW Wilson C see Adams JP Wilson RC see Gilthorpe MS Wirnsberger RM, de Vries J, Breteler MHM, Heck GL van, Wouters SC, Drent M. Evaluation of quality of life in sarcoidosis patients 750-6 Witmeyer P see Devouassoux G Wolfe S see Price DB Wong CF, Yew WW, Chan CY, Au LY, Sheung SW, Cheng AFB. Rapid diagnosis of smear-negative pulmonary tuberculosis via fibreoptic bronchoscopy:

utility of polymerase chain reaction in bronchial aspirates as an adjunct to transbronchial biopsies 815-19 Wong CS see McRae WM Wong S-L see Liu S-F Woods D see Williams T Wouters EFM see Korn SH; Staal-van den Brekel AJ Wouters SC see Wirnsberger RM Wu CP see Ho CL Wu M-F see Perng R-P Wynne HJ see Kampelmacher MJ Xaubet A, Aguste P, Luburich P, Barbera JA, Carrion, Ayuso MC, Rota J, Rodriguez-Roisin R. Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis 33844 Yaekashiwa M see Shiraishi K Yamadori I see Hojo S; Yamanouchi H Yamaji Y see Fujita J; Hojo S Yamamoto T see Nikaido Y Yamanouchi H, Fujita J, Yoshinouchi T, Hojo S, Kamei T, Yamadori 1, Ohtsuki Y, Ueda N, Takahara J. Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis 27338 Yamashita H see Ikeda Y Yamashita N see Ohta T Yamashita Y see Morishima Y Yamashita YT see Ishikawa H Yang C-T see Huang C-C Yasuda N, Gotoh K, Minatoguchi S, Asano K, Nishigaki K, Nomura M, Ohno A, Watanabe M, Sano H, Kumada H, Sawa T, Fujiwara H. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD 993-9 Yasui M see Fujimura M Yazawa T see Morishima Y Yeo JKS see Chee CBE Yew WW see Wong CF Yohannes AM, Roomi J, Waters K, Connolly MJ. Quality of life in elderly patients with COPD: measurement and predictive factors 1231-6 Yoshii C see Nikaido Y Yoshinouchi T see Hojo S; Yamanouchi H Yoshizawa Y see Shishido H Young WF see Thompson PJ Youngchalyyud P see Nana A Yung B, Landers A, Mathalone B, Gyi KM, Hodson ME. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes 871-2 Zacchello F see Baraldi E Zamir D see Weiner P Zetterberg G see Norman M Zetterlund A, Larsson PH, Miiller-Suur C, Palmberg L, Larsson K. Budeonside but not terbulatine decreases phagocytosis in alveolar macrophages 162-6 Zheng L see Striz I Zielhuis GA see Palen .J van der Zissel G, Miiller-Quernheim J. Sarcoidosis: historical perspective and immunopathogenesis (part I) 126-39 Zvas Z see Kreiss Y